KR20200004253A - A plurality of host materials and organic electroluminescent device comprising the same - Google Patents
A plurality of host materials and organic electroluminescent device comprising the same Download PDFInfo
- Publication number
- KR20200004253A KR20200004253A KR1020190078151A KR20190078151A KR20200004253A KR 20200004253 A KR20200004253 A KR 20200004253A KR 1020190078151 A KR1020190078151 A KR 1020190078151A KR 20190078151 A KR20190078151 A KR 20190078151A KR 20200004253 A KR20200004253 A KR 20200004253A
- Authority
- KR
- South Korea
- Prior art keywords
- substituted
- unsubstituted
- compound
- mmol
- alkyl
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 99
- 150000001875 compounds Chemical class 0.000 claims abstract description 211
- 239000000126 substance Substances 0.000 claims abstract description 14
- -1 cyano, carboxyl Chemical group 0.000 claims description 217
- 125000003118 aryl group Chemical group 0.000 claims description 53
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 claims description 45
- 125000001072 heteroaryl group Chemical group 0.000 claims description 38
- 125000005104 aryl silyl group Chemical group 0.000 claims description 30
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 26
- 125000001769 aryl amino group Chemical group 0.000 claims description 24
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- 229910052736 halogen Inorganic materials 0.000 claims description 15
- 150000002367 halogens Chemical class 0.000 claims description 15
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 14
- 229910052805 deuterium Inorganic materials 0.000 claims description 14
- 229910052717 sulfur Inorganic materials 0.000 claims description 14
- 150000002431 hydrogen Chemical class 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 13
- 229910052760 oxygen Inorganic materials 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000003282 alkyl amino group Chemical group 0.000 claims description 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 10
- 125000006822 tri(C1-C30) alkylsilyl group Chemical group 0.000 claims description 10
- 125000001424 substituent group Chemical group 0.000 claims description 9
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 8
- 125000001624 naphthyl group Chemical group 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 6
- 125000005549 heteroarylene group Chemical group 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- 125000000732 arylene group Chemical group 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims description 5
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 5
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 4
- 235000010290 biphenyl Nutrition 0.000 claims description 4
- 239000004305 biphenyl Substances 0.000 claims description 4
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 4
- 125000003914 fluoranthenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC=C4C1=C23)* 0.000 claims description 4
- 125000005956 isoquinolyl group Chemical group 0.000 claims description 4
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 claims description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 4
- 125000004306 triazinyl group Chemical group 0.000 claims description 4
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 claims description 3
- 125000000739 C2-C30 alkenyl group Chemical group 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 3
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 3
- 125000005509 dibenzothiophenyl group Chemical group 0.000 claims description 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- 125000005493 quinolyl group Chemical group 0.000 claims description 3
- 125000001425 triazolyl group Chemical group 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 2
- 125000005110 aryl thio group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 239000010410 layer Substances 0.000 description 122
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 64
- 238000006243 chemical reaction Methods 0.000 description 54
- 238000004440 column chromatography Methods 0.000 description 49
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 48
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 36
- 239000012044 organic layer Substances 0.000 description 34
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 32
- 235000019341 magnesium sulphate Nutrition 0.000 description 32
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 31
- 238000002360 preparation method Methods 0.000 description 30
- 230000015572 biosynthetic process Effects 0.000 description 28
- 238000002347 injection Methods 0.000 description 26
- 239000007924 injection Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 238000003786 synthesis reaction Methods 0.000 description 25
- 229940125898 compound 5 Drugs 0.000 description 24
- 239000000203 mixture Substances 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 239000002019 doping agent Substances 0.000 description 22
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 22
- 238000004821 distillation Methods 0.000 description 21
- 229910000027 potassium carbonate Inorganic materials 0.000 description 18
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 16
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 15
- 230000000903 blocking effect Effects 0.000 description 15
- 230000005525 hole transport Effects 0.000 description 15
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 11
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical group COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 11
- 238000010992 reflux Methods 0.000 description 10
- 238000001771 vacuum deposition Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 125000005842 heteroatom Chemical group 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 238000000151 deposition Methods 0.000 description 8
- 125000002950 monocyclic group Chemical group 0.000 description 8
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 239000001301 oxygen Chemical group 0.000 description 7
- 239000011593 sulfur Chemical group 0.000 description 7
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- KPGPIQKEKAEAHM-UHFFFAOYSA-N 2-chloro-3-phenylquinoxaline Chemical compound ClC1=NC2=CC=CC=C2N=C1C1=CC=CC=C1 KPGPIQKEKAEAHM-UHFFFAOYSA-N 0.000 description 4
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910052796 boron Inorganic materials 0.000 description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- IYYZUPMFVPLQIF-ALWQSETLSA-N dibenzothiophene Chemical group C1=CC=CC=2[34S]C3=C(C=21)C=CC=C3 IYYZUPMFVPLQIF-ALWQSETLSA-N 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 3
- 125000001041 indolyl group Chemical group 0.000 description 3
- 229910052741 iridium Inorganic materials 0.000 description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229940078552 o-xylene Drugs 0.000 description 3
- 239000011368 organic material Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical group C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical group C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- NFHNRZDVWVUUKG-UHFFFAOYSA-N 2,3-dichlorobenzo[f]quinoxaline Chemical compound C1=CC=CC2=C(N=C(C(Cl)=N3)Cl)C3=CC=C21 NFHNRZDVWVUUKG-UHFFFAOYSA-N 0.000 description 2
- HNZUKQQNZRMNGS-UHFFFAOYSA-N 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine Chemical compound BrC1=CC=CC(C=2N=C(N=C(N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 HNZUKQQNZRMNGS-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- HPJYKMSFRBJOSW-JHSUYXJUSA-N Damsin Chemical compound C[C@H]1CC[C@H]2C(=C)C(=O)O[C@H]2[C@]2(C)C(=O)CC[C@@H]12 HPJYKMSFRBJOSW-JHSUYXJUSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FBVBNCGJVKIEHH-UHFFFAOYSA-N [1]benzofuro[3,2-b]pyridine Chemical class C1=CN=C2C3=CC=CC=C3OC2=C1 FBVBNCGJVKIEHH-UHFFFAOYSA-N 0.000 description 2
- WIUZHVZUGQDRHZ-UHFFFAOYSA-N [1]benzothiolo[3,2-b]pyridine Chemical class C1=CN=C2C3=CC=CC=C3SC2=C1 WIUZHVZUGQDRHZ-UHFFFAOYSA-N 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001555 benzenes Chemical group 0.000 description 2
- 150000001716 carbazoles Chemical group 0.000 description 2
- 125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000005299 dibenzofluorenyl group Chemical group C1(=CC=CC2=C3C(=C4C=5C=CC=CC5CC4=C21)C=CC=C3)* 0.000 description 2
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical group C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- 125000001725 pyrenyl group Chemical group 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 125000003003 spiro group Chemical group 0.000 description 2
- 125000001935 tetracenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- PLVCYMZAEQRYHJ-UHFFFAOYSA-N (2-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1Br PLVCYMZAEQRYHJ-UHFFFAOYSA-N 0.000 description 1
- QXBWTYBCNFKURT-UHFFFAOYSA-N (2-methylsulfanylphenyl)boronic acid Chemical compound CSC1=CC=CC=C1B(O)O QXBWTYBCNFKURT-UHFFFAOYSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 1
- OIAQMFOKAXHPNH-UHFFFAOYSA-N 1,2-diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC=C1C1=CC=CC=C1 OIAQMFOKAXHPNH-UHFFFAOYSA-N 0.000 description 1
- 125000004317 1,3,5-triazin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=N1 0.000 description 1
- ORPVVAKYSXQCJI-UHFFFAOYSA-N 1-bromo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1Br ORPVVAKYSXQCJI-UHFFFAOYSA-N 0.000 description 1
- CTPUUDQIXKUAMO-UHFFFAOYSA-N 1-bromo-3-iodobenzene Chemical compound BrC1=CC=CC(I)=C1 CTPUUDQIXKUAMO-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- NXYICUMSYKIABQ-UHFFFAOYSA-N 1-iodo-4-phenylbenzene Chemical group C1=CC(I)=CC=C1C1=CC=CC=C1 NXYICUMSYKIABQ-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- YAVCXSHORWKJQQ-UHFFFAOYSA-N 1-phenyl-2-(2-phenylphenyl)benzene Chemical group C1=CC=CC=C1C1=CC=CC=C1C1=CC=CC=C1C1=CC=CC=C1 YAVCXSHORWKJQQ-UHFFFAOYSA-N 0.000 description 1
- OWPJBAYCIXEHFA-UHFFFAOYSA-N 1-phenyl-3-(3-phenylphenyl)benzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=C(C=CC=2)C=2C=CC=CC=2)=C1 OWPJBAYCIXEHFA-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- MYKQKWIPLZEVOW-UHFFFAOYSA-N 11h-benzo[a]carbazole Chemical class C1=CC2=CC=CC=C2C2=C1C1=CC=CC=C1N2 MYKQKWIPLZEVOW-UHFFFAOYSA-N 0.000 description 1
- ZDPDDOIOIKNGEJ-UHFFFAOYSA-N 11h-indeno[1,2-h]quinoline Chemical class C1=CC=NC2=C3CC4=CC=CC=C4C3=CC=C21 ZDPDDOIOIKNGEJ-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- 125000005810 2,5-xylyl group Chemical group [H]C1=C([H])C(=C(*)C([H])=C1C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- XCNYSGLGEPGIPV-UHFFFAOYSA-N 2-(2-chloroquinazolin-4-yl)-9-phenylcarbazole Chemical compound C=12C=CC=CC2=NC(Cl)=NC=1C(C=1)=CC=C(C2=CC=CC=C22)C=1N2C1=CC=CC=C1 XCNYSGLGEPGIPV-UHFFFAOYSA-N 0.000 description 1
- YTPLUAYRYICPNW-UHFFFAOYSA-N 2-(3-chloroquinoxalin-2-yl)-9-phenylcarbazole Chemical compound ClC=1C(=NC2=CC=CC=C2N=1)C1=CC=2N(C3=CC=CC=C3C=2C=C1)C1=CC=CC=C1 YTPLUAYRYICPNW-UHFFFAOYSA-N 0.000 description 1
- ZCJRWQDZPIIYLM-UHFFFAOYSA-N 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=CC=C1N ZCJRWQDZPIIYLM-UHFFFAOYSA-N 0.000 description 1
- JLGXRQBMJFAZRY-UHFFFAOYSA-N 2-(4-bromonaphthalen-1-yl)-4,6-diphenyl-1,3,5-triazine Chemical compound BrC1=CC=C(C2=CC=CC=C12)C1=NC(=NC(=N1)C1=CC=CC=C1)C1=CC=CC=C1 JLGXRQBMJFAZRY-UHFFFAOYSA-N 0.000 description 1
- AYHGAQGOMUQMTR-UHFFFAOYSA-N 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine Chemical compound C1=CC(Br)=CC=C1C1=NC(C=2C=CC=CC=2)=NC(C=2C=CC=CC=2)=N1 AYHGAQGOMUQMTR-UHFFFAOYSA-N 0.000 description 1
- FARAOARIVJZINN-UHFFFAOYSA-N 2-(4-bromophenyl)-4-phenylquinazoline Chemical compound C1=CC(Br)=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=CC=C2)C2=N1 FARAOARIVJZINN-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- PYMJUVJCJDKIMS-UHFFFAOYSA-N 2-chloro-3-(4-naphthalen-2-ylphenyl)quinoxaline Chemical compound ClC1=NC2=CC=CC=C2N=C1C1=CC=C(C=C1)C1=CC2=CC=CC=C2C=C1 PYMJUVJCJDKIMS-UHFFFAOYSA-N 0.000 description 1
- CQHOIOCXASGZOH-UHFFFAOYSA-N 2-chloro-3-(4-phenylphenyl)quinoxaline Chemical compound C1(=CC=C(C=C1)C1=NC2=CC=CC=C2N=C1Cl)C1=CC=CC=C1 CQHOIOCXASGZOH-UHFFFAOYSA-N 0.000 description 1
- ZZFUMELVAFFMBB-UHFFFAOYSA-N 2-chloro-3-dibenzofuran-1-ylquinoxaline Chemical compound ClC1=NC2=CC=CC=C2N=C1C1=CC=CC=2OC3=C(C=21)C=CC=C3 ZZFUMELVAFFMBB-UHFFFAOYSA-N 0.000 description 1
- XEGAYWQRXAVWSD-UHFFFAOYSA-N 2-chloro-3-naphthalen-1-ylquinoxaline Chemical compound C1=CC=C2C(C3=NC4=CC=CC=C4N=C3Cl)=CC=CC2=C1 XEGAYWQRXAVWSD-UHFFFAOYSA-N 0.000 description 1
- DDGPPAMADXTGTN-UHFFFAOYSA-N 2-chloro-4,6-diphenyl-1,3,5-triazine Chemical compound N=1C(Cl)=NC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 DDGPPAMADXTGTN-UHFFFAOYSA-N 0.000 description 1
- AELILXBWWJSIMK-UHFFFAOYSA-N 2-chloro-4-naphthalen-2-ylquinazoline Chemical compound C1=CC=CC2=NC(Cl)=NC(C=3C=C4C=CC=CC4=CC=3)=C21 AELILXBWWJSIMK-UHFFFAOYSA-N 0.000 description 1
- AYJJTPLDSZAGGA-UHFFFAOYSA-N 2-ethyl-7-methyl-5-(4-methylphenyl)-1,3,4,4a,5,9b-hexahydroindeno[1,2-c]pyridine Chemical class C1N(CC)CCC2C1C1=CC=C(C)C=C1C2C1=CC=C(C)C=C1 AYJJTPLDSZAGGA-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- MUCCHGOWMZTLHK-UHFFFAOYSA-N 2-nitronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=CC2=C1 MUCCHGOWMZTLHK-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- JHNLZOVBAQWGQU-UHFFFAOYSA-N 380814_sial Chemical compound CS(O)(=O)=O.O=P(=O)OP(=O)=O JHNLZOVBAQWGQU-UHFFFAOYSA-N 0.000 description 1
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- JTUZXJXNXMTPTP-UHFFFAOYSA-N 5-chloro-2,3-diphenylquinoxaline Chemical compound C=1C=CC=CC=1C=1N=C2C(Cl)=CC=CC2=NC=1C1=CC=CC=C1 JTUZXJXNXMTPTP-UHFFFAOYSA-N 0.000 description 1
- ORPBDLVVKYEJNL-UHFFFAOYSA-N 6-chloro-2,3-diphenylquinoxaline Chemical compound C=1C=CC=CC=1C1=NC2=CC(Cl)=CC=C2N=C1C1=CC=CC=C1 ORPBDLVVKYEJNL-UHFFFAOYSA-N 0.000 description 1
- FUQHERGPYAMGOQ-UHFFFAOYSA-N 6-chloro-2,4-diphenylquinazoline Chemical compound C12=CC(Cl)=CC=C2N=C(C=2C=CC=CC=2)N=C1C1=CC=CC=C1 FUQHERGPYAMGOQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- GLORZCSFIDGIPP-UHFFFAOYSA-N C1(=CC(=CC=C1)C1=NC2=CC=CC=C2N=C1Cl)C1=CC=CC=C1 Chemical compound C1(=CC(=CC=C1)C1=NC2=CC=CC=C2N=C1Cl)C1=CC=CC=C1 GLORZCSFIDGIPP-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- JKHCVYDYGWHIFJ-UHFFFAOYSA-N Clc1nc(nc(n1)-c1ccc(cc1)-c1ccccc1)-c1ccccc1 Chemical compound Clc1nc(nc(n1)-c1ccc(cc1)-c1ccccc1)-c1ccccc1 JKHCVYDYGWHIFJ-UHFFFAOYSA-N 0.000 description 1
- 101000687716 Drosophila melanogaster SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 homolog Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 101000687741 Mus musculus SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 Proteins 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- CWDFYKZZCSEOPO-UHFFFAOYSA-N [1]benzothiolo[2,3-h]quinoline Chemical class C1=CC=NC2=C3C4=CC=CC=C4SC3=CC=C21 CWDFYKZZCSEOPO-UHFFFAOYSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 125000002078 anthracen-1-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C([*])=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 125000000748 anthracen-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C([H])=C([*])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 150000001545 azulenes Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- GSRFPZLAJMPCOU-UHFFFAOYSA-N benzene 1-benzofuran Chemical compound C1=CC=CC=C1.C1=CC=C2OC=CC2=C1 GSRFPZLAJMPCOU-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000005872 benzooxazolyl group Chemical group 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- ZDZHCHYQNPQSGG-UHFFFAOYSA-N binaphthyl group Chemical group C1(=CC=CC2=CC=CC=C12)C1=CC=CC2=CC=CC=C12 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 description 1
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 1
- UHKPOGGUWJGGID-UHFFFAOYSA-N carbonic acid;cesium Chemical compound [Cs].OC(O)=O UHKPOGGUWJGGID-UHFFFAOYSA-N 0.000 description 1
- QNEFNFIKZWUAEQ-UHFFFAOYSA-N carbonic acid;potassium Chemical compound [K].OC(O)=O QNEFNFIKZWUAEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 1
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 1
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene sulfoxide Natural products C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000005553 heteroaryloxy group Chemical group 0.000 description 1
- 238000004770 highest occupied molecular orbital Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- TVZISJTYELEYPI-UHFFFAOYSA-N hypodiphosphoric acid Chemical compound OP(O)(=O)P(O)(O)=O TVZISJTYELEYPI-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Chemical group CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Chemical group C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- 238000007733 ion plating Methods 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- YGNUPJXMDOFFDO-UHFFFAOYSA-N n,4-diphenylaniline Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1NC1=CC=CC=C1 YGNUPJXMDOFFDO-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002790 naphthalenes Chemical group 0.000 description 1
- 125000004957 naphthylene group Chemical group 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000005551 pyridylene group Chemical group 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 1
- 125000005576 pyrimidinylene group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 1
- 125000005558 triazinylene group Chemical group 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 125000003960 triphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C3=CC=CC=C3C12)* 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 238000002061 vacuum sublimation Methods 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H01L51/0071—
-
- H01L51/5024—
-
- H01L51/52—
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
- H10K50/12—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/80—Constructional details
Landscapes
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
Description
본원은 복수 종의 호스트 재료 및 이를 포함하는 유기 전계 발광 소자에 관한 것이다.The present application relates to a plurality of host materials and organic electroluminescent devices comprising the same.
이스트만 코닥 사의 Tang 등이 1987년에 발광층과 전하 전달층으로 이루어진 TPD/Alq3 이중층 저분자 녹색 유기 전계 발광 소자(OLED)를 처음으로 개발한 이후, 유기 전계 발광 소자에 대한 연구가 급속도로 빠르게 이루어져 현재 상용화에 이르렀다. 현재, 유기 전계 발광 소자는 패널 구현에 있어 발광 효율이 뛰어난 인광 물질을 주로 사용하고 있다. 디스플레이의 장시간 사용과 높은 해상도를 위해서 높은 발광 효율 및/또는 장 수명을 갖는 OLED가 요구되고 있다.Since Eastman Kodak's Tang et al. Developed the first TPD / Alq3 double-layer low molecular green organic electroluminescent device (OLED) consisting of a light emitting layer and a charge transfer layer in 1987, research on organic electroluminescent devices is rapidly and rapidly commercialized. Reached. Currently, organic electroluminescent devices mainly use phosphorescent materials having excellent luminous efficiency in panel implementation. There is a need for OLEDs having high luminous efficiency and / or long life for long time use and high resolution of displays.
발광 효율, 구동 전압 및/또는 수명을 개선시키기 위하여 유기 전계 발광 소자의 유기층에 여러 재료들 또는 컨셉들이 제안되어 왔으나, 현실적으로 사용하기에는 만족스럽지 못하였다.Various materials or concepts have been proposed in the organic layer of the organic electroluminescent device in order to improve luminous efficiency, driving voltage and / or lifetime, but they are not satisfactory for practical use.
한국 특허공개공보 제2015-0121337호는 아줄렌 및 카바졸 등이 융합된 화합물을 개시하나, 복수 종의 호스트 화합물로 사용되는 것을 구체적으로 개시하지 못하며, 여전히 OLED 소자의 성능 향상을 위한 호스트 재료의 개발이 요구되고 있다.Korean Patent Publication No. 2015-0121337 discloses a compound in which azulene, carbazole and the like are fused, but does not specifically disclose that the compound is used as a plurality of host compounds, and still does not provide a host material for improving the performance of OLED devices. Development is required.
본원의 목적은, 특정 조합의 화합물을 포함하는 복수 종의 호스트 재료를 포함함으로써, 양호한 열적 안정성, 낮은 구동전압, 높은 발광효율 및/또는 개선된 수명 특성을 갖는 유기 전계 발광 소자를 제공하는 것이다.It is an object of the present invention to provide an organic electroluminescent device having good thermal stability, low drive voltage, high luminous efficiency and / or improved lifetime characteristics by including a plurality of types of host materials comprising specific combinations of compounds.
인광 도판트를 포함하는 발광층은 저전압, 고효율과 장수명을 위하여 발광층 재료의 정공 및 전자 전류 특성이 우수하며, 수명 향상을 위해 재료의 열적 안정성이 뛰어난 것이 유리하다. 이와 함께 발광층의 호스트에서 도판트로의 효율적인 에너지 전달을 위해서는 좁은 에너지 밴드 갭을 가지는 발광 재료를 사용함으로써 전하 트랩을 최소화하여 구동 전압 및 발광 효율에 기여할 수 있다. 본원의 소자에 포함되는 아줄렌 유도체는 본래 S2→S1의 내부 전환(internal conversion) 전이 상수가 7*10-8 s로 느린 반면, S1→S0의 내부 전환 전이 상수는 7*10-12 s로 빨라 S2→S0의 형광 양자 수율(fluorescence quantum yield)이 증가하여 카샤의 법칙(Kasha's rule)을 위반하는 대표적인 재료 중의 하나이다. 비특허문헌 [Phys. Chem. Chem. Phys. 2015, 17, 23573, J. Phys. Chem. A, Vol. 103, No. 15, 1999 2529]에 의하면 아줄렌의 S2와 S1 준위는 각각 3.565 eV 및 1.771 eV인 반면, T1→S0 전이는 1.711 eV로 매우 작은 T1과 S0의 준위 차이를 보이고 있을 뿐만 아니라, 치환 재료 및 용매의 극성 조건에 따라 S2→Tn로의 계간 교차(intersystem crossing) 전이가 향상되어, 삼중항으로의 전이가 증가하여 인광 발광 특성 향상에 이점이 있을 수 있다는 보고가 있었다. 이러한 아줄렌 유도체는 S1→T1 에너지 갭이 작은 특성을 보이며 카바졸이나 벤조카바졸류 화합물 대비 상대적으로 높은 HOMO 특성을 보여 좁은 에너지 밴드 갭을 가질 수 있다. 본 발명자들은 본원의 아줄렌 유도체를 발광층에 제1 및 제2 호스트로 적절히 발광층 재료로 혼합하여 사용함으로써, 낮은 구동 전압, 높은 효율 및/또는 장수명의 특성을 나타낼 수 있음을 발견하였다. 구체적으로, 1종 이상의 제1 호스트 화합물 및 1종 이상의 제2 호스트 화합물을 포함하는 복수 종의 호스트 재료로서, 상기 제1 호스트 화합물 및 제2 호스트 화합물은 하기 화학식 1로 표시되고, 상기 제1 호스트 화합물과 제2 호스트 화합물은 서로 다른 것인, 호스트 재료가 상술한 목적을 달성함을 발견하여 본 발명을 완성하였다.The light emitting layer including the phosphorescent dopant is excellent in the hole and electron current characteristics of the light emitting layer material for low voltage, high efficiency and long life, and excellent thermal stability of the material to improve the life. In addition, by using a light emitting material having a narrow energy band gap for efficient energy transfer from the host of the light emitting layer to the dopant, the charge trap can be minimized to contribute to the driving voltage and the light emitting efficiency. The azulene derivative included in the device of the present invention originally had a slow internal conversion transition constant of S 2 → S 1 as 7 * 10 −8 s, while the internal conversion transition constant of S 1 → S 0 was 7 * 10. As fast as -12 s, the fluorescence quantum yield of S 2 → S 0 increases, which is one of the representative materials that violates Kasha's rule. Non Patent Literature [Phys. Chem. Chem. Phys. 2015, 17, 23573, J. Phys. Chem. A, Vol. 103, No. 15, 1999 2529], Azulene's S 2 and S 1 levels are 3.565 eV and 1.771 eV, respectively, whereas the T 1 → S 0 transition is 1.711 eV, which shows a very small level difference between T 1 and S 0 . In addition, it has been reported that the intersystem crossing transition from S 2 to T n may be improved according to the polarity of the substitution material and the solvent, and the transition to triplet may be increased, thereby improving the phosphorescence properties. These azulene derivatives have a small S 1 → T 1 energy gap and may have a narrow energy band gap because of relatively high HOMO characteristics compared to carbazole or benzocarbazole compounds. The present inventors have found that by using the azulene derivative of the present application as a light emitting layer material by mixing the light emitting layer as the first and second hosts as appropriate, it can exhibit the characteristics of low driving voltage, high efficiency and / or long life. Specifically, a plurality of host materials including at least one first host compound and at least one second host compound, wherein the first host compound and the second host compound are represented by the following Formula 1, and the first host The present invention has been completed by discovering that the host material achieves the above-mentioned object, wherein the compound and the second host compound are different.
[화학식 1][Formula 1]
상기 화학식 1에서,In Chemical Formula 1,
M은 , O 또는 S이고;M is , O or S;
X1 내지 X12는 각각 독립적으로 N 또는 CR1이며;X 1 to X 12 are each independently N or CR 1 ;
La는 단일결합, 치환 또는 비치환된 (C1-C30)알킬렌, 치환 또는 비치환된 (C6-C30)아릴렌, 치환 또는 비치환된 (3-30원)헤테로아릴렌, 또는 치환 또는 비치환된 (C3-C30)시클로알킬렌이고;La is a single bond, substituted or unsubstituted (C1-C30) alkylene, substituted or unsubstituted (C6-C30) arylene, substituted or unsubstituted (3- to 30-membered) heteroarylene, or substituted or unsubstituted Ring (C3-C30) cycloalkylene;
Ar 및 R1은 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (3-30원)헤테로아릴, 치환 또는 비치환된 (C3-C30)시클로알킬, 치환 또는 비치환된 (C1-C30)알콕시, 치환 또는 비치환된 트리(C1-C30)알킬실릴, 치환 또는 비치환된 디(C1-C30)알킬(C6-C30)아릴실릴, 치환 또는 비치환된 (C1-C30)알킬디(C6-C30)아릴실릴, 치환 또는 비치환된 트리(C6-C30)아릴실릴, 치환 또는 비치환된 모노- 또는 디- (C1-C30)알킬아미노, 치환 또는 비치환된 모노- 또는 디- (C6-C30)아릴아미노, 또는 치환 또는 비치환된 (C1-C30)알킬(C6-C30)아릴아미노이거나; 인접한 Ar끼리 서로 연결되어 고리를 형성하거나, 인접한 R1끼리 서로 연결되어 고리를 형성할 수 있고, R1이 복수인 경우 각각의 R1은 서로 동일하거나 상이할 수 있으며;Ar and R 1 are each independently hydrogen, deuterium, halogen, cyano, substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl, substituted or unsubstituted (3-30 Heteroaryl, substituted or unsubstituted (C3-C30) cycloalkyl, substituted or unsubstituted (C1-C30) alkoxy, substituted or unsubstituted tri (C1-C30) alkylsilyl, substituted or unsubstituted di (C1-C30) alkyl (C6-C30) arylsilyl, substituted or unsubstituted (C1-C30) alkyldi (C6-C30) arylsilyl, substituted or unsubstituted tri (C6-C30) arylsilyl, substituted or Unsubstituted mono- or di- (C1-C30) alkylamino, substituted or unsubstituted mono- or di- (C6-C30) arylamino, or substituted or unsubstituted (C1-C30) alkyl (C6-C30) Arylamino; Adjacent Ar are connected to each other to form a ring, or may form a ring are connected to each other, the adjacent R 1, if R 1 is plural, each of R 1 are the same or may be different from one another, and;
a는 1 또는 2의 정수이고, a가 2인 경우, 각각의 Ar은 동일하거나 상이할 수 있다.a is an integer of 1 or 2, and when a is 2, each Ar may be the same or different.
본원에 따른 복수 종의 호스트 재료를 포함함으로써, 양호한 열적 안정성, 낮은 구동전압, 높은 발광효율 및/또는 개선된 수명 특성을 갖는 유기 전계 발광 소자가 제공되며, 이를 이용한 표시 장치 또는 조명 장치의 제조가 가능하다.By including a plurality of host materials according to the present application, an organic electroluminescent device having good thermal stability, low driving voltage, high luminous efficiency and / or improved lifespan characteristics is provided, and manufacturing of a display device or a lighting device using the same It is possible.
이하에서 본원을 더욱 상세히 설명하나, 이는 설명을 위한 것으로 본원의 범위를 제한하도록 해석되어서는 안 된다.The present application is described in more detail below, but for the purpose of description and should not be construed to limit the scope of the present application.
본원에서 "유기 전계 발광 재료"는 유기 전계 발광 소자에 사용될 수 있는 재료를 의미하고, 1종 이상의 화합물을 포함할 수 있으며, 필요에 따라 유기 전계 발광 소자를 구성하는 임의의 층에 포함될 수 있다. 예를 들면, 상기 유기 전계 발광 재료는 정공 주입 재료, 정공 전달 재료, 정공 보조 재료, 발광 보조 재료, 전자 차단 재료, 발광 재료(호스트 재료 및 도판트 재료 포함), 전자 버퍼 재료, 정공 차단 재료, 전자 전달 재료, 전자 주입 재료 등일 수 있다.As used herein, "organic electroluminescent material" means a material that can be used in an organic electroluminescent device, and may include one or more compounds, and may be included in any layer constituting the organic electroluminescent device as needed. For example, the organic electroluminescent material may be a hole injection material, a hole transport material, a hole auxiliary material, a light emission auxiliary material, an electron blocking material, a light emitting material (including a host material and a dopant material), an electron buffer material, a hole blocking material, Electron transport material, electron injection material, and the like.
본원에서 "복수 종의 유기 전계 발광 재료"는 유기 전계 발광 소자를 구성하는 임의의 층에 포함될 수 있는 2종 이상의 화합물이 조합된 유기 전계 발광 재료를 의미하고, 유기 전계 발광 소자에 포함되기 전 (예를 들면, 증착 전) 및 포함된 후 (예를 들면, 증착 후)의 재료를 모두 의미할 수 있다. 예를 들면, 복수 종의 유기 전계 발광 재료는 정공주입층, 정공전달층, 정공보조층, 발광보조층, 전자차단층, 발광층, 전자버퍼층, 정공차단층, 전자전달층 및 전자주입층 중 하나 이상의 층에 포함될 수 있는 화합물이 2종 이상 조합된 것일 수 있다. 이러한 2종 이상의 화합물들은 같은 층 또는 다른 층에 포함될 수 있고, 혼합증착 또는 공증착되거나, 개별적으로 증착될 수 있다.As used herein, "plural kinds of organic electroluminescent materials" means organic electroluminescent materials in which two or more compounds that can be included in any layer constituting the organic electroluminescent device are combined, and before being included in the organic electroluminescent device ( For example, it can mean both before and after the deposition (eg, after deposition). For example, the plurality of organic electroluminescent materials may include one of a hole injection layer, a hole transport layer, a hole auxiliary layer, a light emitting auxiliary layer, an electron blocking layer, a light emitting layer, an electron buffer layer, a hole blocking layer, an electron transport layer, and an electron injection layer. The compound which may be included in the above layer may be a combination of two or more kinds. These two or more compounds may be included in the same layer or in different layers and may be mixed or co-deposited or deposited separately.
본원에서 "복수 종의 호스트 재료"는 유기 전계 발광 소자를 구성하는 임의의 발광층에 포함될 수 있는 2종 이상의 화합물의 조합을 포함하는 호스트 재료를 의미하고, 유기 전계 발광 소자에 포함되기 전(예를 들면, 증착 전) 및 포함된 후(예를 들면, 증착 후)의 재료를 모두 의미할 수 있다. 일례로, 본원의 복수 종의 호스트 재료는 2종 이상의 호스트 재료가 조합된 것으로서, 선택적으로, 유기 전계 발광 재료에 포함되는 통상의 물질을 추가로 포함한 것일 수 있다. 본원의 복수 종의 호스트 재료는 유기 전계 발광 소자를 구성하는 임의의 발광층에 포함될 수 있는데, 상기 복수 종의 호스트 재료에 포함된 2종 이상의 화합물은 하나의 발광층에 함께 포함될 수도 있고, 각각 다른 발광층에 포함될 수도 있다. 2종 이상의 호스트 재료가 하나의 층에 포함되는 경우, 예를 들어, 혼합증착되어 층을 형성할 수도 있고, 별도로 동시에 공증착되어 층을 형성할 수도 있다.As used herein, "plural species of host material" means a host material comprising a combination of two or more compounds that may be included in any light emitting layer constituting the organic electroluminescent device, and is not included in the organic electroluminescent device (e.g., For example, before and after the deposition (eg, after deposition), the material may mean both. In one example, the plurality of host materials of the present application is a combination of two or more host materials, optionally, may further include a conventional material included in the organic electroluminescent material. The plurality of host materials of the present application may be included in any light emitting layer constituting the organic electroluminescent device, and two or more compounds included in the plurality of host materials may be included together in one light emitting layer, and may be included in different light emitting layers, respectively. May be included. When two or more host materials are included in one layer, for example, they may be mixed-deposited to form a layer, or they may be separately co-deposited simultaneously to form a layer.
상기 화학식 1로 표시되는 화합물에 대해 보다 구체적으로 설명하면 다음과 같다.Hereinafter, the compound represented by Chemical Formula 1 will be described in more detail.
본원에서 "(C1-C30)알킬(렌)"은 쇄를 구성하는 탄소수가 1 내지 30개인 직쇄 또는 분지쇄 알킬(렌)을 의미하고, 여기에서 탄소수는 바람직하게는 1 내지 20개, 더 바람직하게는 1 내지 10개이다. 상기 알킬의 구체적인 예로서, 메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸 및 tert-부틸 등이 있다. 본원에서 "(C2-C30)알케닐"은 쇄를 구성하는 탄소수가 2 내지 30개인 직쇄 또는 분지쇄 알케닐을 의미하고, 여기에서 탄소수는 바람직하게는 2 내지 20개, 더 바람직하게는 2 내지 10개이다. 상기 알케닐의 구체적인 예로서, 비닐, 1-프로페닐, 2-프로페닐, 1-부테닐, 2-부테닐, 3-부테닐, 2-메틸부트-2-에닐 등이 있다. 본원에서 "(C2-C30)알키닐"은 쇄를 구성하는 탄소수가 2 내지 30개인 직쇄 또는 분지쇄 알키닐을 의미하고, 여기에서 탄소수는 바람직하게는 2 내지 20개, 더 바람직하게는 2 내지 10개이다. 상기 알키닐의 예로서, 에티닐, 1-프로피닐, 2-프로피닐, 1-부티닐, 2-부티닐, 3-부티닐, 1-메틸펜트-2-이닐 등이 있다. 본원에서 "(C3-C30)시클로알킬(렌)"은 환 골격 탄소수가 3 내지 30개인 단일환 또는 다환 탄화수소를 의미하고, 상기 탄소수는 바람직하게는 3 내지 20개, 더 바람직하게는 3 내지 7개이다. 상기 시클로알킬의 예로서, 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실 등이 있다. 본원에서 "(3-7원)헤테로시클로알킬"은 환 골격 원자수가 3 내지 7개, 바람직하게는 5 내지 7개이고, B, N, O, S, Si 및 P로 이루어진 군, 바람직하게는 O, S 및 N로 이루어진 군에서 선택되는 하나 이상의 헤테로원자를 포함하는 시클로알킬을 의미하고, 예를 들어, 테트라하이드로푸란, 피롤리딘, 티올란, 테트라하이드로피란 등이 있다. 본원에서 "(C6-C30)아릴(렌)"은 환 골격 탄소수가 6 내지 30개인 방향족 탄화수소에서 유래된 단일환 또는 융합환계 라디칼을 의미하고, 부분적으로 포화될 수도 있다. 상기 환 골격 탄소수는 바람직하게는 6 내지 25개, 더 바람직하게는 6 내지 18개이다. 상기 아릴은 스피로 구조를 가진 것을 포함한다. 상기 아릴의 예로서, 페닐, 비페닐, 터페닐, 나프틸, 비나프틸, 페닐나프틸, 나프틸페닐, 페닐터페닐, 플루오레닐, 페닐플루오레닐, 벤조플루오레닐, 디벤조플루오레닐, 페난트레닐, 페닐페난트레닐, 안트라세닐, 인데닐, 트리페닐레닐, 피레닐, 테트라세닐, 페릴레닐, 크라이세닐, 나프타세닐, 플루오란테닐, 스피로비플루오레닐 등이 있다. 더욱 구체적으로는, 페닐기, 1-나프틸기, 2-나프틸기, 1-안트릴기, 2-안트릴기, 9-안트릴기, 벤즈안트릴기, 1-페난트릴기, 2-페난트릴기, 3-페난트릴기, 4-페난트릴기, 9-페난트릴기, 나프타세닐기, 피레닐기, 1-크리세닐기, 2-크리세닐기, 3-크리세닐기, 4-크리세닐기, 5-크리세닐기, 6-크리세닐기, 벤조[c]페난트릴기, 벤조[g]크리세닐기, 1-트리페닐레닐기, 2-트리페닐레닐기, 3-트리페닐레닐기, 4-트리페닐레닐기, 1-플루오레닐기, 2-플루오레닐기, 3-플루오레닐기, 4-플루오레닐기, 9-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 2-비페닐일기, 3-비페닐일기, 4-비페닐일기, o-터페닐기, m-터페닐-4-일기, m-터페닐-3-일기, m-터페닐-2-일기, p-터페닐-4-일기, p-터페닐-3-일기, p-터페닐-2-일기, m-쿼터페닐기, 3-플루오란테닐기, 4-플루오란테닐기, 8-플루오란테닐기, 9-플루오란테닐기, 벤조플루오란테닐기, o-톨릴기, m-톨릴기, p-톨릴기, 2,3-자일릴기, 3,4-자일릴기, 2,5-자일릴기, 메시틸기, o-쿠멘일기, m-쿠멘일기, p-쿠멘일기, p-t-부틸페닐기, p-(2-페닐프로필)페닐기, 4'-메틸비페닐일기, 4"-t-부틸-p-터페닐-4-일기, 9,9-디메틸-1-플루오레닐기, 9,9-디메틸-2-플루오레닐기, 9,9-디메틸-3-플루오레닐기, 9,9-디메틸-4-플루오레닐기, 9,9-디페닐-1-플루오레닐기, 9,9-디페닐-2-플루오레닐기, 9,9-디페닐-3-플루오레닐기, 9,9-디페닐-4-플루오레닐기를 들 수 있다.As used herein, "(C1-C30) alkyl (ene)" means a straight or branched chain alkyl (ene) having 1 to 30 carbon atoms constituting the chain, wherein the carbon number is preferably 1 to 20, more preferably Preferably it is 1-10. Specific examples of the alkyl include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and tert-butyl. As used herein, "(C2-C30) alkenyl" means a straight or branched chain alkenyl having 2 to 30 carbon atoms constituting the chain, wherein the carbon number is preferably 2 to 20, more preferably 2 to 10. Specific examples of the alkenyl include vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 2-methylbut-2-enyl and the like. As used herein, "(C2-C30) alkynyl" means a straight or branched chain alkynyl having 2 to 30 carbon atoms constituting the chain, wherein the carbon number is preferably 2 to 20, more preferably 2 to 10. Examples of the alkynyl include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methylpent-2-ynyl and the like. As used herein, "(C3-C30) cycloalkyl (ene)" means a monocyclic or polycyclic hydrocarbon having 3 to 30 ring skeleton carbon atoms, and the carbon number is preferably 3 to 20, more preferably 3 to 7 Dog. Examples of the cycloalkyl include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like. As used herein, "(3-7 membered) heterocycloalkyl" has 3 to 7, preferably 5 to 7 ring skeleton atoms, and is a group consisting of B, N, O, S, Si and P, preferably O , Cycloalkyl comprising at least one heteroatom selected from the group consisting of S and N, and examples thereof include tetrahydrofuran, pyrrolidine, thiolane, tetrahydropyran and the like. As used herein, "(C6-C30) aryl (ene)" means a monocyclic or fused ring radical derived from an aromatic hydrocarbon having 6 to 30 ring backbone carbon atoms, and may be partially saturated. The ring skeleton carbon number is preferably 6 to 25, more preferably 6 to 18. The aryl includes those having a spiro structure. Examples of the aryl include phenyl, biphenyl, terphenyl, naphthyl, binaphthyl, phenylnaphthyl, naphthylphenyl, phenylterphenyl, fluorenyl, phenylfluorenyl, benzofluorenyl, dibenzoflu Orenyl, phenanthrenyl, phenylphenanthrenyl, anthracenyl, indenyl, triphenylenyl, pyrenyl, tetrasenyl, peryllenyl, chrysenyl, naphthacenyl, fluoranthenyl, spirobifluorenyl and the like. . More specifically, a phenyl group, 1-naphthyl group, 2-naphthyl group, 1-anthryl group, 2-anthryl group, 9-anthryl group, benzanthryl group, 1-phenanthryl group, 2-phenanthryl Group, 3-phenanthryl group, 4-phenanthryl group, 9-phenanthryl group, naphthacenyl group, pyrenyl group, 1-crisenyl group, 2-crissenyl group, 3-crissenyl group, 4-crissenyl group , 5-crisenyl group, 6-crisenyl group, benzo [c] phenanthryl group, benzo [g] chrysenyl group, 1-triphenylenyl group, 2-triphenylenyl group, 3-triphenylenyl group, 4-triphenylenyl group, 1-fluorenyl group, 2-fluorenyl group, 3-fluorenyl group, 4-fluorenyl group, 9-fluorenyl group, benzofluorenyl group, dibenzofluorenyl group, 2- Biphenylyl group, 3-biphenylyl group, 4-biphenylyl group, o-terphenyl group, m-terphenyl-4-yl group, m-terphenyl-3-yl group, m-terphenyl-2-yl group, p- Terphenyl-4-yl group, p-terphenyl-3-yl group, p-terphenyl-2-yl group, m-quaterphenyl group, 3-fluoranthenyl group, 4-fluoranthenyl group, 8-fluoranthenyl group , 9- Laurantenyl group, benzofluoranthenyl group, o-tolyl group, m-tolyl group, p-tolyl group, 2,3-xylyl group, 3,4-xylyl group, 2,5-xylyl group, mesityl group, o-cumenyl group, m-cumenyl group, p-cumenyl group, pt-butylphenyl group, p- (2-phenylpropyl) phenyl group, 4'-methylbiphenylyl group, 4 "-t-butyl-p-terphenyl- 4-yl group, 9,9-dimethyl-1-fluorenyl group, 9,9-dimethyl-2-fluorenyl group, 9,9-dimethyl-3-fluorenyl group, 9,9-dimethyl-4-fluore Neyl group, 9,9-diphenyl-1-fluorenyl group, 9,9-diphenyl-2-fluorenyl group, 9,9-diphenyl-3-fluorenyl group, 9,9-diphenyl-4- Fluorenyl group is mentioned.
본원에서 "(3-30원)헤테로아릴(렌)"은 환 골격 원자수가 3 내지 30개이고, B, N, O, S, Si 및 P로 이루어진 군에서 선택된 하나 이상의 헤테로원자를 포함하는 아릴기를 의미한다. 헤테로원자수는 바람직하게는 1 내지 4개이고, 단일 환계이거나 하나 이상의 벤젠환과 축합된 융합환계일 수 있으며, 부분적으로 포화될 수도 있다. 또한, 본원에서 상기 헤테로아릴(렌)은 하나 이상의 헤테로아릴 또는 아릴기가 단일 결합에 의해 헤테로아릴기와 연결된 형태도 포함하며, 스피로 구조를 가진 것도 포함한다. 상기 헤테로아릴의 예로서, 푸릴, 티오펜일, 피롤릴, 이미다졸릴, 피라졸릴, 티아졸릴, 티아디아졸릴, 이소티아졸릴, 이속사졸릴, 옥사졸릴, 옥사디아졸릴, 트리아진일, 테트라진일, 트리아졸릴, 테트라졸릴, 푸라잔일, 피리딜, 피라진일, 피리미딘일, 피리다진일 등의 단일 환계 헤테로아릴, 벤조푸란일, 벤조티오펜일, 이소벤조푸란일, 디벤조푸란일, 디벤조티오펜일, 벤조이미다졸릴, 벤조티아졸릴, 벤조이소티아졸릴, 벤조이속사졸릴, 벤조옥사졸릴, 이소인돌릴, 인돌릴, 벤조인돌릴, 인다졸릴, 벤조티아디아졸릴, 퀴놀릴, 이소퀴놀릴, 신놀리닐, 퀴나졸리닐, 벤조퀴나졸리닐, 퀴녹살리닐, 벤조퀴녹살리닐, 나프티리디닐, 카바졸릴, 벤조카바졸릴, 디벤조카바졸릴, 페녹사진일, 페노티아진일, 페난트리딘일, 벤조디옥솔릴, 디하이드로아크리디닐 등의 융합 환계 헤테로아릴 등이 있다. 더욱 구체적으로는, 1-피롤릴기, 2-피롤릴기, 3-피롤릴기, 피라지닐기, 2-피리디닐기, 2-피리미디닐기, 4-피리미디닐기, 5-피리미디닐기, 6-피리미디닐기, 1,2,3-트리아진-4-일기, 1,2,4-트리아진-3-일기, 1,3,5-트리아진-2-일기, 1-이미다졸릴기, 2-이미다졸릴기, 1-피라졸릴기, 1-인돌리디닐기, 2-인돌리디닐기, 3-인돌리디닐기, 5-인돌리디닐기, 6-인돌리디닐기, 7-인돌리디닐기, 8-인돌리디닐기, 2-이미다조피리디닐기, 3-이미다조피리디닐기, 5-이미다조피리디닐기, 6-이미다조피리디닐기, 7-이미다조피리디닐기, 8-이미다조피리디닐기, 3-피리디닐기, 4-피리디닐기, 1-인돌릴기, 2-인돌릴기, 3-인돌릴기, 4-인돌릴기, 5-인돌릴기, 6-인돌릴기, 7-인돌릴기, 1-이소인돌릴기, 2-이소인돌릴기, 3-이소인돌릴기, 4-이소인돌릴기, 5-이소인돌릴기, 6-이소인돌릴기, 7-이소인돌릴기, 2-푸릴기, 3-푸릴기, 2-벤조푸라닐기, 3-벤조푸라닐기, 4-벤조푸라닐기, 5-벤조푸라닐기, 6-벤조푸라닐기, 7-벤조푸라닐기, 1-이소벤조푸라닐기, 3-이소벤조푸라닐기, 4-이소벤조푸라닐기, 5-이소벤조푸라닐기, 6-이소벤조푸라닐기, 7-이소벤조푸라닐기, 2-퀴놀릴기, 3-퀴놀릴기, 4-퀴놀릴기, 5-퀴놀릴기, 6-퀴놀릴기, 7-퀴놀릴기, 8-퀴놀릴기, 1-이소퀴놀릴기, 3-이소퀴놀릴기, 4-이소퀴놀릴기, 5-이소퀴놀릴기, 6-이소퀴놀릴기, 7-이소퀴놀릴기, 8-이소퀴놀릴기, 2-퀴녹살리닐기, 5-퀴녹살리닐기, 6-퀴녹살리닐기, 1-카바졸릴기, 2-카바졸릴기, 3-카바졸릴기, 4-카바졸릴기, 9-카바졸릴기, 아자카바졸릴-1-일기, 아자카바졸릴-2-일기, 아자카바졸릴-3-일기, 아자카바졸릴-4-일기, 아자카바졸릴-5-일기, 아자카바졸릴-6-일기, 아자카바졸릴-7-일기, 아자카바졸릴-8-일기, 아자카바졸릴-9-일기, 1-페난트리디닐기, 2-페난트리디닐기, 3-페난트리디닐기, 4-페난트리디닐기, 6-페난트리디닐기, 7-페난트리디닐기, 8-페난트리디닐기, 9-페난트리디닐기, 10-페난트리디닐기, 1-아크리디닐기, 2-아크리디닐기, 3-아크리디닐기, 4-아크리디닐기, 9-아크리디닐기, 2-옥사졸릴기, 4-옥사졸릴기, 5-옥사졸릴기, 2-옥사디아졸릴기, 5-옥사디아졸릴기, 3-푸라자닐기, 2-티에닐기, 3-티에닐기, 2-메틸피롤-1-일기, 2-메틸피롤-3-일기, 2-메틸피롤-4-일기, 2-메틸피롤-5-일기, 3-메틸피롤-1-일기, 3-메틸피롤-2-일기, 3-메틸피롤-4-일기, 3-메틸피롤-5-일기, 2-t-부틸피롤-4-일기, 3-(2-페닐프로필)피롤-1-일기, 2-메틸-1-인돌릴기, 4-메틸-1-인돌릴기, 2-메틸-3-인돌릴기, 4-메틸-3-인돌릴기, 2-t-부틸-1-인돌릴기, 4-t-부틸-1-인돌릴기, 2-t-부틸-3-인돌릴기, 4-t-부틸-3-인돌릴기, 1-디벤조푸라닐기, 2-디벤조푸라닐기, 3-디벤조푸라닐기, 4-디벤조푸라닐기, 1-디벤조티오페닐기, 2-디벤조티오페닐기, 3-디벤조티오페닐기, 4-디벤조티오페닐기, 1-실라플루오레닐기, 2-실라플루오레닐기, 3-실라플루오레닐기, 4-실라플루오레닐기, 1-게르마플루오레닐기, 2-게르마플루오레닐기, 3-게르마플루오레닐기, 4-게르마플루오레닐기를 들 수 있다. 본원에서 "할로겐"은 F, Cl, Br 및 I 원자를 포함한다.As used herein, "(3- to 30-membered) heteroaryl (ene)" is an aryl group having 3 to 30 ring skeleton atoms and containing at least one heteroatom selected from the group consisting of B, N, O, S, Si and P. it means. The number of heteroatoms is preferably 1 to 4, and may be a single ring system or a fused ring system condensed with one or more benzene rings, and may be partially saturated. In addition, the heteroaryl (ene) herein also includes a form in which one or more heteroaryl or an aryl group is connected to a heteroaryl group by a single bond, and includes a spiro structure. Examples of the heteroaryl include furyl, thiophenyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, thiadiazolyl, isothiazolyl, isoxazolyl, oxazolyl, oxdiazolyl, triazinyl, tetrazinyl Monocyclic heteroaryl such as triazolyl, tetrazolyl, furazanyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, benzofuranyl, benzothiophenyl, isobenzofuranyl, dibenzofuranyl, di Benzothiophenyl, benzoimidazolyl, benzothiazolyl, benzoisothiazolyl, benzoisoxazolyl, benzooxazolyl, isoindolinyl, indolyl, benzoindolyl, indazolyl, benzothiadiazolyl, quinolyl, iso Quinolyl, cinnolinyl, quinazolinyl, benzoquinazolinyl, quinoxalinyl, benzoquinoxalinyl, naphthyridinyl, carbazolyl, benzocarbazolyl, dibenzocarbazolyl, phenoxazylyl, phenothiazineyl, Such as phenanthridinyl, benzodioxolyl, dihydroacridinyl It must include heteroaryl ring systems. More specifically, 1-pyrrolyl group, 2-pyrrolyl group, 3-pyrrolyl group, pyrazinyl group, 2-pyridinyl group, 2-pyrimidinyl group, 4-pyrimidinyl group, 5-pyrimidinyl group, 6- Pyrimidinyl, 1,2,3-triazin-4-yl, 1,2,4-triazin-3-yl, 1,3,5-triazin-2-yl, 1-imidazolyl, 2-imidazolyl group, 1-pyrazolyl group, 1-indolidinyl group, 2-indolidinyl group, 3-indolidinyl group, 5-indolidinyl group, 6-indolidinyl group, 7-indolidinyl group, 8 -Indolidinyl group, 2-imidazopyridinyl group, 3-imidazopyridinyl group, 5-imidazopyridinyl group, 6-imidazopyridinyl group, 7-imidazopyridinyl group, 8-imidazopi Ridinyl group, 3-pyridinyl group, 4-pyridinyl group, 1-indolyl group, 2-indolyl group, 3-indolyl group, 4-indolyl group, 5-indolyl group, 6-indolyl group, 7-indolyl group, 1-isoindolyl group, 2-isoindolyl group, 3-isoindolyl group, 4-isoindolyl group, 5-isoindolyl group, 6-isoindolyl group, 7-isoindolyl group, 2 -Fu Group, 3-furyl group, 2-benzofuranyl group, 3-benzofuranyl group, 4-benzofuranyl group, 5-benzofuranyl group, 6-benzofuranyl group, 7-benzofuranyl group, 1-isobenzofuranyl group, 3-isobenzofuranyl group, 4-isobenzofuranyl group, 5-isobenzofuranyl group, 6-isobenzofuranyl group, 7-isobenzofuranyl group, 2-quinolyl group, 3-quinolyl group, 4-qui Tealyl, 5-quinolyl, 6-quinolyl, 7-quinolyl, 8-quinolyl, 1-isoquinolyl, 3-isoquinolyl, 4-isoquinolyl, 5- Isoquinolyl group, 6-isoquinolyl group, 7-isoquinolyl group, 8-isoquinolyl group, 2-quinoxalinyl group, 5-quinoxalinyl group, 6-quinoxalinyl group, 1-carbazolyl group, 2-carbazolyl group, 3-carbazolyl group, 4-carbazolyl group, 9-carbazolyl group, azacarbazolyl-1-yl group, azacarbazolyl-2-yl group, azacarbazolyl-3-yl group, azakaba Azocarbazolyl-9-, Azocarbazolyl-5-, Azacarbazolyl-6-, Azacarbazolyl-7-, Azacarbazolyl-8-, Group, 1-phenantridinyl group, 2-phenantridinyl group, 3-phenantridinyl group, 4-phenantridinyl group, 6-phenantridinyl group, 7-phenantridinyl group, 8-phenantridinyl group , 9-phenantridinyl group, 10-phenantridinyl group, 1-acridinyl group, 2-acridinyl group, 3-acridinyl group, 4-acridinyl group, 9-acridinyl group, 2-oxazolyl group , 4-oxazolyl group, 5-oxazolyl group, 2-oxadiazolyl group, 5-oxadiazolyl group, 3-furazanyl group, 2-thienyl group, 3-thienyl group, 2-methylpyrrole-1- Diary, 2-methylpyrrole-3-yl group, 2-methylpyrrole-4-yl group, 2-methylpyrrole-5-yl group, 3-methylpyrrole-1-yl group, 3-methylpyrrole-2-yl group, 3-methyl Pyrrole-4-yl group, 3-methylpyrrole-5-yl group, 2-t-butylpyrrole-4-yl group, 3- (2-phenylpropyl) pyrrole-1-yl group, 2-methyl-1-indolyl group, 4 -Methyl-1-indolyl group, 2-methyl-3-indolyl group, 4-methyl-3-indolyl group, 2-t-butyl-1-indolyl group, 4-t-butyl-1-indolyl group, 2- t-butyl-3-indolyl group, 4-t-butyl-3-indolyl group, 1-dibenzofuranyl group, 2 -Dibenzofuranyl group, 3-dibenzofuranyl group, 4-dibenzofuranyl group, 1-dibenzothiophenyl group, 2-dibenzothiophenyl group, 3-dibenzothiophenyl group, 4-dibenzothiophenyl group, 1- Silafluorenyl, 2-silafluorenyl, 3-silafluorenyl, 4-silafluorenyl, 1-germafluorenyl, 2-germafluorenyl, 3-germafluorenyl, 4-germafluorenyl group is mentioned. "Halogen" herein includes F, Cl, Br and I atoms.
또한, 본원에 기재되어 있는 "치환 또는 비치환"이라는 기재에서 "치환"은 어떤 작용기에서 수소 원자가 다른 원자 또는 다른 작용기 (즉, 치환기)로 대체되는 것을 뜻한다. 본원 화학식들에서의 치환된 (C1-C30)알킬(렌), 치환된 (C6-C30)아릴(렌), 치환된 (3-30원)헤테로아릴(렌), 치환된 (C3-C30)시클로알킬(렌), 치환된 (C1-C30)알콕시, 치환된 트리(C1-C30)알킬실릴, 치환된 디(C1-C30)알킬(C6-C30)아릴실릴, 치환된 (C1-C30)알킬디(C6-C30)아릴실릴, 치환된 트리(C6-C30)아릴실릴, 치환된 모노- 또는 디- (C1-C30)알킬아미노, 치환된 모노- 또는 디- (C6-C30)아릴아미노, 및 치환된 (C1-C30)알킬(C6-C30)아릴아미노의 치환기는 각각 독립적으로 중수소, 할로겐, 시아노, 카르복실, 니트로, 히드록시, (C1-C30)알킬, 할로(C1-C30)알킬, (C2-C30)알케닐, (C2-C30)알키닐, (C1-C30)알콕시, (C1-C30)알킬티오, (C3-C30)시클로알킬, (C3-C30)시클로알케닐, (3-7원)헤테로시클로알킬, (C6-C30)아릴옥시, (C6-C30)아릴티오, (C6-C30)아릴로 치환 또는 비치환된 (3-30 원)헤테로아릴, (3-30원)헤테로아릴로 치환 또는 비치환된 (C6-C30)아릴, 트리(C1-C30)알킬실릴, 트리(C6-C30)아릴실릴, 디(C1-C30)알킬(C6-C30)아릴실릴, (C1-C30)알킬디(C6-C30)아릴실릴, 아미노, 모노- 또는 디- (C1-C30)알킬아미노, (C1-C30)알킬로 치환 또는 비치환된 모노- 또는 디- (C6-C30)아릴아미노, (C1-C30)알킬(C6-C30)아릴아미노, (C1-C30)알킬카보닐, (C1-C30)알콕시카보닐, (C6-C30)아릴카보닐, 디(C6-C30)아릴보로닐, 디(C1-C30)알킬보로닐, (C1-C30)알킬(C6-C30)아릴보로닐, (C6-C30)아르(C1-C30)알킬, 및 (C1-C30)알킬(C6-C30)아릴로 이루어진 군으로부터 선택되는 하나 이상일 수 있고, 바람직하게는 (C1-C20)알킬, 비치환된 (C6-C25)아릴, 및 (C6-C25)아릴로 치환 또는 비치환된 (5-25원)헤테로아릴로 이루어진 군으로부터 선택되는 하나 이상이고, 더욱 바람직하게는 (C1-C10)알킬, 비치환된 (C6-C18)아릴, 및 (C6-C18)아릴로 치환된 (5-18원)헤테로아릴로 이루어진 군으로부터 선택되는 하나 이상이고, 예를 들면, 메틸, 페닐, 디페닐트리아진일 및 페닐퀴녹살리닐로 이루어진 군으로부터 선택되는 하나 이상일 수 있다.In addition, in the description of "substituted or unsubstituted" as described herein, "substituted" means that a hydrogen atom is replaced by another atom or another functional group (ie a substituent) in a certain functional group. Substituted (C1-C30) alkyl (lene), substituted (C6-C30) aryl (ene), substituted (3- to 30-membered) heteroaryl (ene), substituted (C3-C30) in the formulas herein Cycloalkyl (ene), substituted (C1-C30) alkoxy, substituted tri (C1-C30) alkylsilyl, substituted di (C1-C30) alkyl (C6-C30) arylsilyl, substituted (C1-C30) Alkyldi (C6-C30) arylsilyl, substituted tri (C6-C30) arylsilyl, substituted mono- or di- (C1-C30) alkylamino, substituted mono- or di- (C6-C30) arylamino And the substituents of substituted (C1-C30) alkyl (C6-C30) arylamino are each independently deuterium, halogen, cyano, carboxyl, nitro, hydroxy, (C1-C30) alkyl, halo (C1-C30) ) Alkyl, (C2-C30) alkenyl, (C2-C30) alkynyl, (C1-C30) alkoxy, (C1-C30) alkylthio, (C3-C30) cycloalkyl, (C3-C30) cycloalkenyl (3-30 membered) heteroaryl unsubstituted or substituted with (3-7 membered) heterocycloalkyl, (C6-C30) aryloxy, (C6-C30) arylthio, (C6-C30) aryl, and (3 Heteroaryloxy Or unsubstituted (C6-C30) aryl, tri (C1-C30) alkylsilyl, tri (C6-C30) arylsilyl, di (C1-C30) alkyl (C6-C30) arylsilyl, (C1-C30) alkyl Mono (or di- (C6-C30) arylamino, unsubstituted or substituted with di (C6-C30) arylsilyl, amino, mono- or di- (C1-C30) alkylamino, (C1-C30) alkyl, ( C1-C30) alkyl (C6-C30) arylamino, (C1-C30) alkylcarbonyl, (C1-C30) alkoxycarbonyl, (C6-C30) arylcarbonyl, di (C6-C30) arylboroyl , Di (C1-C30) alkylboronyl, (C1-C30) alkyl (C6-C30) arylboronyl, (C6-C30) ar (C1-C30) alkyl, and (C1-C30) alkyl (C6 -C30) aryl may be one or more selected from the group consisting of (C1-C20) alkyl, unsubstituted (C6-C25) aryl, and (C6-C25) aryl substituted or unsubstituted (5 -25 membered) at least one selected from the group consisting of heteroaryl, and more preferably (5- substituted with (C1-C10) alkyl, unsubstituted (C6-C18) aryl, and (C6-C18) aryl Heteroaryl At least one selected from the group consisting of, for example, may be at least one selected from the group consisting of methyl, phenyl, diphenyltriazinyl and phenylquinoxalinyl.
본원 화학식에서, 인접한 치환기와 연결되어 고리를 형성 또는 두 개의 인접한 치환기가 서로 연결되어 고리를 형성하는 경우, 상기 고리는 치환 또는 비치환된 (3-30원)의 단일환 또는 다환의 지환족, 방향족 또는 이들의 조합의 고리일 수 있다. 또한, 형성된 고리는 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자를 포함할 수 있다. 예를 들면, 상기 융합된 고리는 치환 또는 비치환된 디벤조티오펜 고리, 치환 또는 비치환된 디벤조푸란 고리, 치환 또는 비치환된 나프탈렌 고리, 치환 또는 비치환된 페난트렌 고리, 치환 또는 비환된 플루오렌 고리, 치환 또는 비치환된 벤조티오펜 고리, 치환 또는 비치환된 벤조푸란 고리, 치환 또는 비치환된 인돌 고리, 치환 또는 비치환된 인덴 고리, 치환 또는 비치환된 벤젠 고리 또는 치환 또는 비치환된 카바졸 고리 형태일 수 있다.In the general formula of the present application, when connected to an adjacent substituent to form a ring or when two adjacent substituents are connected to each other to form a ring, the ring is substituted or unsubstituted (3- to 30-membered) monocyclic or polycyclic alicyclic ring, Aromatic or combinations thereof. In addition, the ring formed may comprise one or more heteroatoms selected from nitrogen, oxygen and sulfur. For example, the fused ring may be substituted or unsubstituted dibenzothiophene ring, substituted or unsubstituted dibenzofuran ring, substituted or unsubstituted naphthalene ring, substituted or unsubstituted phenanthrene ring, substituted or acyclic Fluorene ring, substituted or unsubstituted benzothiophene ring, substituted or unsubstituted benzofuran ring, substituted or unsubstituted indole ring, substituted or unsubstituted indene ring, substituted or unsubstituted benzene ring or substituted or It may be in the form of an unsubstituted carbazole ring.
본원 화학식에서, 헤테로아릴 또는 헤테로아릴렌은 각각 독립적으로, B, N, O, S, Si 및 P로부터 선택된 하나 이상의 헤테로원자를 포함할 수 있다. 또한, 상기 헤테로원자는 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (5-30원)헤테로아릴, 치환 또는 비치환된 (C3-C30)시클로알킬, 치환 또는 비치환된 (C1-C30)알콕시, 치환 또는 비치환된 트리(C1-C30)알킬실릴, 치환 또는 비치환된 디(C1-C30)알킬(C6-C30)아릴실릴, 치환 또는 비치환된 (C1-C30)알킬디(C6-C30)아릴실릴, 치환 또는 비치환된 트리(C6-C30)아릴실릴, 치환 또는 비치환된 모노- 또는 디- (C1-C30)알킬아미노, 치환 또는 비치환된 모노- 또는 디- (C6-C30)아릴아미노, 및 치환 또는 비치환된 (C1-C30)알킬(C6-C30)아릴아미노로 이루어진 군으로부터 선택되는 하나 이상이 결합될 수 있다.In the formulas herein, heteroaryl or heteroarylene may each independently comprise one or more heteroatoms selected from B, N, O, S, Si and P. Further, the heteroatom may be hydrogen, deuterium, halogen, cyano, substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl, substituted or unsubstituted (5- to 30-membered) Heteroaryl, substituted or unsubstituted (C3-C30) cycloalkyl, substituted or unsubstituted (C1-C30) alkoxy, substituted or unsubstituted tri (C1-C30) alkylsilyl, substituted or unsubstituted di (C1) -C30) alkyl (C6-C30) arylsilyl, substituted or unsubstituted (C1-C30) alkyldi (C6-C30) arylsilyl, substituted or unsubstituted tri (C6-C30) arylsilyl, substituted or unsubstituted Mono- or di- (C1-C30) alkylamino, substituted or unsubstituted mono- or di- (C6-C30) arylamino, and substituted or unsubstituted (C1-C30) alkyl (C6-C30) aryl One or more selected from the group consisting of amino may be bonded.
상기 화학식 1에서, M은 , O 또는 S이다.In Formula 1, M is , O or S.
상기 화학식 1에서, X1 내지 X12는 각각 독립적으로 N 또는 CR1이다. 본원의 일 양태에 따르면, X1 내지 X12는 모두 CR1일 수 있고, 본원의 다른 일 양태에 따르면, X1 내지 X12 중 어느 하나는 N일 수 있고, 본원의 또 다른 일 양태에 따르면, 두 개의 X1 내지 X12는 N일 수 있다.In Formula 1, X 1 to X 12 are each independently N or CR 1 . According to an aspect of the present disclosure, X 1 to X 12 may all be CR 1 , and according to another aspect of the present disclosure, any one of X 1 to X 12 may be N, and according to another aspect of the present disclosure , X 2 to X 12 may be N.
상기 화학식 1에서, La는 단일 결합, 치환 또는 비치환된 (C1-C30)알킬렌, 치환 또는 비치환된 (C6-C30)아릴렌, 치환 또는 비치환된 (3-30원)헤테로아릴렌, 또는 치환 또는 비치환된 (C3-C30)시클로알킬렌이며, 바람직하게는 단일 결합, 치환 또는 비치환된 (C6-C25)아릴렌, 또는 치환 또는 비치환된 (5-25원)헤테로아릴렌이며, 더욱 바람직하게는 단일 결합, 비치환된 (C6-C18)아릴렌, 또는 비치환된 (5-18원)헤테로아릴렌이다. 상기 헤테로아릴렌은 질소, 산소 및 황 중 하나 이상을 포함할 수 있으며, 바람직하게는 질소 및 황 중 하나 이상을 포함할 수 있다. 본원의 일 양태에 따르면, La는 단일 결합, 페닐렌, 나프틸렌, 비페닐렌, 피리딜렌, 피리미디닐렌, 트리아지닐렌, 이소퀴놀리닐렌, 퀴나졸리닐렌, 나프티리디닐렌, 퀴녹살리닐렌, 벤조퀴녹살리닐렌, 인돌로퀴녹살리닐렌, 벤조티에노피리미디닐렌, 또는 벤조퀴나졸리닐렌일 수 있다. In Formula 1, La is a single bond, substituted or unsubstituted (C1-C30) alkylene, substituted or unsubstituted (C6-C30) arylene, substituted or unsubstituted (3- to 30-membered) heteroarylene Or substituted or unsubstituted (C3-C30) cycloalkylene, preferably a single bond, substituted or unsubstituted (C6-C25) arylene, or substituted or unsubstituted (5- to 25-membered) heteroaryl Ren, more preferably a single bond, unsubstituted (C6-C18) arylene, or unsubstituted (5- to 18-membered) heteroarylene. The heteroarylene may include one or more of nitrogen, oxygen and sulfur, and preferably may include one or more of nitrogen and sulfur. According to an aspect of the present application, La is a single bond, phenylene, naphthylene, biphenylene, pyridylene, pyrimidinylene, triazinylene, isoquinolinylene, quinazolinylene, naphthyridinylene, quinoxalinylene, Benzoquinoxalinylene, indoloquinoxalinylene, benzothienopyrimidinylene, or benzoquinazolinylene.
상기 화학식 1에서, Ar 및 R1은 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (3-30원)헤테로아릴, 치환 또는 비치환된 (C3-C30)시클로알킬, 치환 또는 비치환된 (C1-C30)알콕시, 치환 또는 비치환된 트리(C1-C30)알킬실릴, 치환 또는 비치환된 디(C1-C30)알킬(C6-C30)아릴실릴, 치환 또는 비치환된 (C1-C30)알킬디(C6-C30)아릴실릴, 치환 또는 비치환된 트리(C6-C30)아릴실릴, 치환 또는 비치환된 모노- 또는 디- (C1-C30)알킬아미노, 치환 또는 비치환된 모노- 또는 디- (C6-C30)아릴아미노, 또는 치환 또는 비치환된 (C1-C30)알킬(C6-C30)아릴아미노이거나; 인접한 Ar끼리 서로 연결되어 고리를 형성하거나, 인접한 R1끼리 서로 연결되어 고리를 형성할 수 있고, R1이 복수인 경우 각각의 R1은 서로 동일하거나 상이할 수 있다. In Formula 1, Ar and R 1 are each independently hydrogen, deuterium, halogen, cyano, substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl, substituted or unsubstituted Substituted (3-30 membered) heteroaryl, substituted or unsubstituted (C3-C30) cycloalkyl, substituted or unsubstituted (C1-C30) alkoxy, substituted or unsubstituted tri (C1-C30) alkylsilyl, substituted Or unsubstituted di (C1-C30) alkyl (C6-C30) arylsilyl, substituted or unsubstituted (C1-C30) alkyldi (C6-C30) arylsilyl, substituted or unsubstituted tri (C6-C30) Arylsilyl, substituted or unsubstituted mono- or di- (C1-C30) alkylamino, substituted or unsubstituted mono- or di- (C6-C30) arylamino, or substituted or unsubstituted (C1-C30) Alkyl (C6-C30) arylamino; Adjacent Ar may be connected to each other to form a ring, or adjacent R 1 may be connected to each other to form a ring. When R 1 is plural, each R 1 may be the same or different from each other.
상기 Ar은 바람직하게는 치환 또는 비치환된 (C6-C25)아릴, 치환 또는 비치환된 (5-25원)헤테로아릴, 또는 치환 또는 비치환된 디(C6-C25)아릴아미노일 수 있고, 더욱 바람직하게는 비치환된 (C6-C18)아릴, (C1-C10)알킬 및/또는 (C6-C12)아릴로 치환 또는 비치환된 (5-25원)헤테로아릴, 또는 (C1-C6)알킬로 치환 또는 비치환된 디(C6-C25)아릴아미노일 수 있다. 본원의 일 양태에 따르면, Ar은 치환 또는 비치환된 페닐, 치환 또는 비치환된 나프틸, 치환 또는 비치환된 비페닐, 치환 또는 비치환된 터페닐, 치환 또는 비치환된 플루오레닐, 치환 또는 비치환된 플루오란테닐, 치환 또는 비치환된 트리아진일, 치환 또는 비치환된 피리딜, 치환 또는 비치환된 피리미딘일, 치환 또는 비치환된 벤조티에노피리미딘일, 치환 또는 비치환된 아세나프토피리미딘일, 치환 또는 비치환된 퀴나졸리닐, 치환 또는 비치환된 벤조퀴나졸리닐, 치환 또는 비치환된 퀴녹살리닐, 치환 또는 비치환된 벤조퀴녹살리닐, 치환 또는 비치환된 디벤조퀴녹살리닐, 치환 또는 비치환된 퀴놀릴, 치환 또는 비치환된 벤조퀴놀릴, 치환 또는 비치환된 이소퀴놀릴, 치환 또는 비치환된 벤조이소퀴놀릴, 치환 또는 비치환된 벤조티에노퀴놀릴, 치환 또는 비치환된 벤조푸로퀴놀릴, 치환 또는 비치환된 트리아졸릴, 치환 또는 비치환된 피라졸릴, 치환 또는 비치환된 카바졸릴, 치환 또는 비치환된 디벤조티오펜일, 치환 또는 비치환된 벤조티오펜일, 치환 또는 비치환된 디벤조푸란일, 치환 또는 비치환된 벤조푸란일, 치환 또는 비치환된 나프티리디닐, 치환 또는 비치환된 벤조티아졸리닐, 치환 또는 비치환된 페난트로이미다졸릴, 치환 또는 비치환된 디페닐아미노, 치환 또는 비치환된 페닐비페닐아미노, 치환 또는 비치환된 플루오레닐페닐아미노, 치환 또는 비치환된 디벤조티오펜일페닐아미노, 또는 치환 또는 비치환된 디벤조푸란일페닐아미노일 수 있다. 본원의 다른 일 양태에 따르면, Ar은 중수소 및 나프틸 중 하나 이상으로 치환 또는 비치환된 페닐; 비치환된 나프틸; 비치환된 비페닐; 하나 이상의 메틸로 치환된 플루오레닐; 비치환된 플루오란테닐; 페닐 및 나프틸 중 하나 이상으로 치환 또는 비치환된 트리아진일; 하나 이상의 페닐로 치환 또는 비치환된 피리딜; 하나 이상의 페닐로 치환 또는 비치환된 피리미딘일; 하나 이상의 페닐로 치환된 퀴나졸리닐; 하나 이상의 페닐로 치환된 이소퀴놀릴; 하나 이상의 페닐로 치환 또는 비치환된 카바졸릴; 비치환된 디벤조티오펜일; 비치환된 디벤조푸란일; 하나 이상의 페닐로 치환된 나프티리디닐; 비치환된 디페닐아미노; 비치환된 페닐비페닐아미노; 디메틸플루오레닐페닐아미노; 하나 이상의 페닐로 치환된 벤조티에노피리미딘일; 비치환된 벤조티에노퀴놀릴; 비치환된 벤조푸로퀴놀릴; 하나 이상의 페닐로 치환된 벤조퀴나졸리닐; 하나 이상의 페닐로 치환된 벤조티아졸리닐; 하나 이상의 페닐로 치환된 벤조퀴녹살리닐; 비치환된 디벤조퀴녹살리닐; 하나 이상의 페닐로 치환된 페난트로이미다졸릴; 비치환된 디벤조티오펜일페닐아미노; 비치환된 디벤조푸란일페닐아미노; 하나 이상의 메틸로 치환된 질소 함유 17원 헤테로아릴; 질소 및 산소 함유 25원 헤테로아릴; 또는 하나 이상의 페닐로 치환된 아세나프토피리미딘일일 수 있다.Ar may preferably be substituted or unsubstituted (C6-C25) aryl, substituted or unsubstituted (5- to 25-membered) heteroaryl, or substituted or unsubstituted di (C6-C25) arylamino, More preferably, (5- to 25-membered) heteroaryl unsubstituted or substituted with (C6-C18) aryl, (C1-C10) alkyl and / or (C6-C12) aryl, or (C1-C6) Di (C6-C25) arylamino unsubstituted or substituted with alkyl. According to an aspect of the present application, Ar is substituted or unsubstituted phenyl, substituted or unsubstituted naphthyl, substituted or unsubstituted biphenyl, substituted or unsubstituted terphenyl, substituted or unsubstituted fluorenyl, substituted Or unsubstituted fluoranthenyl, substituted or unsubstituted triazinyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted benzothienopyrimidinyl, substituted or unsubstituted Acenaphtopyrimidinyl, substituted or unsubstituted quinazolinyl, substituted or unsubstituted benzoquinazolinyl, substituted or unsubstituted quinoxalinyl, substituted or unsubstituted benzoquinoxalinyl, substituted or unsubstituted di Benzoquinoxalinyl, substituted or unsubstituted quinolyl, substituted or unsubstituted benzoquinolyl, substituted or unsubstituted isoquinolyl, substituted or unsubstituted benzoisoquinolyl, substituted or unsubstituted benzothienoquinolyl , Chi Or unsubstituted benzofuroquinolyl, substituted or unsubstituted triazolyl, substituted or unsubstituted pyrazolyl, substituted or unsubstituted carbazolyl, substituted or unsubstituted dibenzothiophenyl, substituted or unsubstituted benzo Thiophenyl, substituted or unsubstituted dibenzofuranyl, substituted or unsubstituted benzofuranyl, substituted or unsubstituted naphthyridinyl, substituted or unsubstituted benzothiazolinyl, substituted or unsubstituted phenanthromimida Zolyl, substituted or unsubstituted diphenylamino, substituted or unsubstituted phenylbiphenylamino, substituted or unsubstituted fluorenylphenylamino, substituted or unsubstituted dibenzothiophenylphenylamino, or substituted or unsubstituted Dibenzofuranylphenylamino. According to another aspect of the present application, Ar is phenyl unsubstituted or substituted with one or more of deuterium and naphthyl; Unsubstituted naphthyl; Unsubstituted biphenyl; Fluorenyl substituted with one or more methyl; Unsubstituted fluoranthenyl; Triazinyl unsubstituted or substituted with one or more of phenyl and naphthyl; Pyridyl unsubstituted or substituted with one or more phenyl; Pyrimidinyl unsubstituted or substituted with one or more phenyl; Quinazolinyl substituted with one or more phenyl; Isoquinolyl substituted with one or more phenyl; Carbazolyl unsubstituted or substituted with one or more phenyl; Unsubstituted dibenzothiophenyl; Unsubstituted dibenzofuranyl; Naphthyridinyl substituted with one or more phenyl; Unsubstituted diphenylamino; Unsubstituted phenylbiphenylamino; Dimethylfluorenylphenylamino; Benzothienopyrimidinyl substituted with one or more phenyl; Unsubstituted benzothienoquinolyl; Unsubstituted benzofuroquinolyl; Benzoquinazolinyl substituted with one or more phenyl; Benzothiazolinyl substituted with one or more phenyl; Benzoquinoxalinyl substituted with one or more phenyl; Unsubstituted dibenzoquinoxalinyl; Phenanthroimidazolyl substituted with one or more phenyl; Unsubstituted dibenzothiophenylphenylamino; Unsubstituted dibenzofuranylphenylamino; Nitrogen-containing 17-membered heteroaryl substituted with one or more methyl; 25 membered heteroaryl containing nitrogen and oxygen; Or acenaphtopyrimidinyl substituted with one or more phenyl.
상기 R1은 바람직하게는 치환 또는 비치환된 (C6-C25)아릴, 또는 치환 또는 비치환된 (3-25원)헤테로아릴이거나; 인접한 R1끼리 서로 연결되어 치환 또는 비치환된 (3-25원)의 단일환 또는 다환의 지환족, 방향족 또는 이들의 조합의 고리를 형성할 수 있고, 상기 형성된 지환족, 방향족 또는 이들의 조합의 고리의 탄소 원자는 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자로 대체될 수 있고, 더욱 바람직하게는 치환 또는 비치환된 (C6-C18)아릴, 또는 치환 또는 비치환된 (5-18원)헤테로아릴이거나; 인접한 R1끼리 서로 연결되어 치환 또는 비치환된 (3-18원)의 단일환 또는 다환의 방향족 고리를 형성할 수 있고, 상기 형성된 방향족 고리의 탄소 원자는 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자로 대체될 수 있고, 더더욱 바람직하게는 (5-18원)헤테로아릴로 치환 또는 비치환된 (C6-C12)아릴, 또는 (C6-C18)아릴로 치환 또는 비치환된 (5-13원)헤테로아릴이거나; 인접한 R1끼리 서로 연결되어 치환 또는 비치환된 (3-10원)의 단일환 또는 다환의 방향족 고리를 형성할 수 있고, 상기 형성된 방향족 고리의 탄소 원자는 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자로 대체될 수 있다. 본원의 일 양태에 따르면, R1은 디페닐트리아진일로 치환 또는 비치환된 페닐, 디페닐트리아진일, 페닐로 치환된 퀴나졸리닐, 또는 비치환된 피리딜이거나, 인접한 R1끼리 서로 연결되어 비치환된 벤젠 고리, 메틸 및 페닐 중 하나 이상으로 치환된 인덴 고리, 비치환된 피리딘 고리, 비치환된 벤조티오펜 고리, 비치환된 벤조푸란 고리, 또는 페닐 또는 페닐퀴녹살리닐로 치환된 인돌 고리를 형성할 수 있다.R 1 is preferably substituted or unsubstituted (C6-C25) aryl, or substituted or unsubstituted (3- to 25-membered) heteroaryl; Adjacent R 1 's may be linked to each other to form a substituted or unsubstituted (3- to 25-membered) monocyclic or polycyclic alicyclic, aromatic, or combination ring thereof, and the alicyclic, aromatic, or combination thereof formed as described above. The carbon atoms of the ring of may be replaced with one or more heteroatoms selected from nitrogen, oxygen and sulfur, more preferably substituted or unsubstituted (C6-C18) aryl, or substituted or unsubstituted (5- to 18-membered) Heteroaryl; Adjacent R 1 's may be linked to each other to form a substituted or unsubstituted (3- to 18-membered) monocyclic or polycyclic aromatic ring, wherein the carbon atoms of the formed aromatic ring are at least one selected from nitrogen, oxygen and sulfur (5-6-membered) unsubstituted or substituted with (C6-C12) aryl, or (C6-C18) aryl unsubstituted or substituted with a (5- to 18-membered) heteroaryl, and more preferably Heteroaryl; Adjacent R 1 's may be linked to each other to form a substituted or unsubstituted (3-10 membered) monocyclic or polycyclic aromatic ring, wherein the carbon atoms of the formed aromatic ring are one or more selected from nitrogen, oxygen and sulfur It may be replaced with a heteroatom. According to an aspect of the present application, R 1 is phenyl unsubstituted or substituted with diphenyltriazinyl, diphenyltriazinyl, quinazolinyl substituted with phenyl, or unsubstituted pyridyl, or adjacent R 1 are connected to each other. Indene ring substituted with one or more of unsubstituted benzene rings, methyl and phenyl, unsubstituted pyridine ring, unsubstituted benzothiophene ring, unsubstituted benzofuran ring, or indole substituted with phenyl or phenylquinoxalinyl May form a ring.
본원의 일 태양에 따르면, 화학식 1에서, X1 내지 X12 중 인접한 두 개가 CR1이고, 인접한 두 개의 R1이 연결되어 하기 화학식 2 내지 6 중 어느 하나의 고리를 형성할 수 있고, 상기 고리는 화학식 1로 표시되는 하나의 화합물에서 하나 이상 형성될 수 있다. 예를 들면, 상기 고리는 디벤조티오펜 고리, 디벤조푸란 고리, 나프탈렌 고리, 페난트렌 고리, 또는 치환 또는 비치환된 카바졸 고리일 수 있다.According to an aspect of the present disclosure, in Formula 1, two adjacent X 1 to X 12 may be CR 1 , and two adjacent R 1 may be connected to form a ring of any one of Formulas 2 to 6, wherein the ring One or more may be formed in one compound represented by the formula (1). For example, the ring may be a dibenzothiophene ring, a dibenzofuran ring, a naphthalene ring, a phenanthrene ring, or a substituted or unsubstituted carbazole ring.
[화학식 2] [화학식 3] [화학식 4] [화학식 5] [화학식 6][Formula 2] [Formula 3] [Formula 4] [Formula 5] [Formula 6]
상기 화학식 2 내지 6에서, 는 CR1에서의 C와 R1의 연결 부위를 나타낸다. In Chemical Formulas 2 to 6, Represents the joint of the C and R 1 of the CR 1.
상기 화학식 4에서, X는 N 또는 CH이다. 본원의 일 양태에 따르면, X는 모두 CH일 수 있고, 본원의 다른 일 양태에 따르면, X 중 어느 하나는 N일 수 있다.In Formula 4, X is N or CH. According to an aspect of the present disclosure, X may be all CH, and according to another aspect of the present disclosure, any one of X may be N.
상기 화학식 5에서, R2는 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (3-30원)헤테로아릴, 치환 또는 비치환된 (C3-C30)시클로알킬, 치환 또는 비치환된 (C1-C30)알콕시, 치환 또는 비치환된 트리(C1-C30)알킬실릴, 치환 또는 비치환된 디(C1-C30)알킬(C6-C30)아릴실릴, 치환 또는 비치환된 (C1-C30)알킬디(C6-C30)아릴실릴, 치환 또는 비치환된 트리(C6-C30)아릴실릴, 치환 또는 비치환된 모노- 또는 디- (C1-C30)알킬아미노, 치환 또는 비치환된 모노- 또는 디- (C6-C30)아릴아미노, 또는 치환 또는 비치환된 (C1-C30)알킬(C6-C30)아릴아미노이고, 바람직하게는 치환 또는 비치환된 (C6-C25)아릴, 또는 치환 또는 비치환된 (5-25원)헤테로아릴이고, 더욱 바람직하게는 비치환된 (C6-C18)아릴, 또는 (C6-C18)아릴로 치환 또는 비치환된 (5-18원)헤테로아릴이다. 본원의 일 양태에 따르면, R2는 비치환된 페닐, 또는 페닐로 치환된 퀴녹살리닐일 수 있다.In Formula 5, R 2 is hydrogen, deuterium, halogen, cyano, substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl, substituted or unsubstituted (3-30 Heteroaryl, substituted or unsubstituted (C3-C30) cycloalkyl, substituted or unsubstituted (C1-C30) alkoxy, substituted or unsubstituted tri (C1-C30) alkylsilyl, substituted or unsubstituted di (C1-C30) alkyl (C6-C30) arylsilyl, substituted or unsubstituted (C1-C30) alkyldi (C6-C30) arylsilyl, substituted or unsubstituted tri (C6-C30) arylsilyl, substituted or Unsubstituted mono- or di- (C1-C30) alkylamino, substituted or unsubstituted mono- or di- (C6-C30) arylamino, or substituted or unsubstituted (C1-C30) alkyl (C6-C30) ) Arylamino, preferably substituted or unsubstituted (C6-C25) aryl, or substituted or unsubstituted (5- to 25-membered) heteroaryl, more preferably unsubstituted (C6-C18) aryl, Or substituted with (C6-C18) aryl or Substituted (5-18 W) is heteroaryl. According to an aspect of the present application, R 2 may be unsubstituted phenyl or quinoxalinyl substituted with phenyl.
상기 화학식 6에서, R11 및 R12는 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (3-30원)헤테로아릴, 또는 치환 또는 비치환된 (C3-C30)시클로알킬이거나; 서로 연결되어 고리를 형성할 수 있으며, 바람직하게는 R11 및 R12는 각각 독립적으로 수소, 치환 또는 비치환된 (C1-C6)알킬, 또는 치환 또는 비치환된 (C6-C12)아릴이거나; 서로 연결되어 치환 또는 비치환된 (5-10원)의 단일환 또는 다환의 지환족, 방향족 또는 이들의 조합의 고리를 형성할 수 있고, 더욱 바람직하게는, 각각 독립적으로 수소, 비치환된 (C1-C6)알킬, 또는 비치환된 (C6-C12)아릴이거나; 서로 연결되어 스파이로 고리를 형성할 수 있다. In Formula 6, R 11 and R 12 are each independently hydrogen, deuterium, halogen, cyano, substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl, substituted or unsubstituted Substituted (3- to 30-membered) heteroaryl, or substituted or unsubstituted (C3-C30) cycloalkyl; May be linked to each other to form a ring, preferably R 11 and R 12 are each independently hydrogen, substituted or unsubstituted (C1-C6) alkyl, or substituted or unsubstituted (C6-C12) aryl; Connected to each other to form a substituted or unsubstituted (5- to 10-membered) monocyclic or polycyclic alicyclic, aromatic, or a combination thereof, and more preferably, each independently hydrogen, unsubstituted ( C1-C6) alkyl, or unsubstituted (C6-C12) aryl; They can be linked together to form a ring with a spy.
상기 화학식 1에서, a는 1 또는 2의 정수이고, a가 2인 경우, 각각의 Ar은 동일하거나 상이할 수 있다.In Formula 1, a is an integer of 1 or 2, when a is 2, each Ar may be the same or different.
상기 화학식 1의 화합물은 하기 화학식 7 내지 10 중 적어도 하나로 표시될 수 있다.The compound of Formula 1 may be represented by at least one of the following Chemical Formulas 7 to 10.
[화학식 7] [화학식 8][Formula 7] [Formula 8]
[화학식 9] [화학식 10][Formula 9] [Formula 10]
상기 화학식 7 내지 10에서, X1 내지 X12, 및 M은 화학식 1에서 정의된 바와 같다.In Formulas 7 to 10, X 1 to X 12 , and M are as defined in formula (1).
본원의 일양태에 따르면, X1 내지 X5 중 하나 이상, X6 내지 X9 중 하나 이상, 및 X10 내지 X12 중 하나 이상은 N 또는 CR1이고, 여기서 R1은 각각 독립적으로 치환 또는 비치환된 (C6-C25)아릴, 또는 치환 또는 비치환된 (3-25원)헤테로아릴이거나; 인접한 치환기와 연결되어 치환 또는 비치환된 (3-25원)의 단일환 또는 다환의 지환족, 방향족 또는 이들의 조합의 고리를 형성할 수 있고, 상기 형성된 지환족, 방향족 또는 이들의 조합의 고리의 탄소 원자는 질소, 산소 및 황으로부터 선택되는 하나 이상의 헤테로원자로 대체될 수 있다.According to one aspect of the present disclosure, at least one of X 1 to X 5 , at least one of X 6 to X 9 , and at least one of X 10 to X 12 are N or CR 1 , wherein each R 1 is independently substituted or Unsubstituted (C6-C25) aryl, or substituted or unsubstituted (3- to 25-membered) heteroaryl; Connected to an adjacent substituent to form a substituted or unsubstituted (3- to 25-membered) monocyclic or polycyclic alicyclic, aromatic, or combination thereof ring, wherein the alicyclic, aromatic, or combination thereof formed ring May be replaced with one or more heteroatoms selected from nitrogen, oxygen and sulfur.
본원의 일양태에 따르면, 상기 제1 호스트 화합물의 화학식 1에서 Ar이 치환 또는 비치환된 (3-30원)헤테로아릴이고, 상기 제2 호스트 화합물의 화학식 1에서 Ar이 치환 또는 비치환된 (3-30원)헤테로아릴일 수 있다.According to an embodiment of the present disclosure, in Formula 1 of the first host compound, Ar is substituted or unsubstituted (3- to 30-membered) heteroaryl, and in Formula 1 of the second host compound, Ar is substituted or unsubstituted ( 3-30 membered) heteroaryl.
본원의 다른 일양태에 따르면, 상기 제1 호스트 화합물의 화학식 1의 Ar이 치환 또는 비치환된 (3-30원)헤테로아릴이고, 상기 제2 호스트 화합물의 화학식 1의 Ar이 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 모노- 또는 디- (C1-C30)알킬아미노, 치환 또는 비치환된 모노- 또는 디- (C6-C30)아릴아미노, 또는 치환 또는 비치환된 (C1-C30)알킬(C6-C30)아릴아미노일 수 있다.According to another embodiment of the present application, Ar in Formula 1 of the first host compound is substituted or unsubstituted (3- to 30-membered) heteroaryl, and Ar in Formula 1 of the second host compound is substituted or unsubstituted. (C6-C30) aryl, substituted or unsubstituted mono- or di- (C1-C30) alkylamino, substituted or unsubstituted mono- or di- (C6-C30) arylamino, or substituted or unsubstituted ( C1-C30) alkyl (C6-C30) arylamino.
상기 화학식 1로 표시되는 화합물은 보다 구체적으로 하기의 화합물로서 예시될 수 있으나, 이들에 한정되는 것은 아니다.The compound represented by Chemical Formula 1 may be exemplified more specifically as the following compound, but is not limited thereto.
상기 화합물 C-1 내지 C-449 중 둘 이상이 조합되어 유기 전계 발광 소자에 사용될 수 있다.Two or more of the compounds C-1 to C-449 may be used in combination in an organic electroluminescent device.
본원에 따른 화학식 1의 화합물은 당업자에게 공지된 합성 방법으로 제조할 수 있으며, 예를 들면 하기 반응식 1 내지 7에 나타난 바와 같이 제조할 수 있으나, 이에 한정되지는 않는다.The compound of formula 1 according to the present invention may be prepared by synthetic methods known to those skilled in the art, for example, it may be prepared as shown in Schemes 1 to 7, but is not limited thereto.
[반응식 1]Scheme 1
[반응식 2]Scheme 2
[반응식 3]Scheme 3
[반응식 4]Scheme 4
[반응식 5] Scheme 5
[반응식 6]Scheme 6
[반응식 7]Scheme 7
상기 반응식 1 내지 7에서 X1 내지 X12, R1, La, Ar 및 a는 화학식 1에서의 정의와 동일하고, R2, R11 및 R12는 화학식 5 및 6에서의 정의와 동일하며, Z는 R1의 정의와 동일하고, OTf는 트리플루오로메탄설포네이트이다.In Schemes 1 to 7, X 1 to X 12 , R 1 , La, Ar, and a are the same as defined in Formula 1, R 2 , R 11 and R 12 are the same as defined in Formulas 5 and 6, Z is as defined in R 1 and OTf is trifluoromethanesulfonate.
본원에 따른 유기 전계 발광 소자는 제1전극; 제2전극; 및 상기 제1전극 및 제2전극 사이에 개재되는 1층 이상의 유기물층을 갖는다.The organic electroluminescent device according to the present invention comprises a first electrode; Second electrode; And at least one organic material layer interposed between the first electrode and the second electrode.
상기 제1전극과 제2전극 중 하나는 애노드이고 다른 하나는 캐소드일 수 있다. 상기 유기물층은 발광층을 포함하고, 정공 주입층, 정공 전달층, 정공 보조층, 발광 보조층, 전자 전달층, 전자 버퍼층, 전자 주입층, 계면층(interlayer), 정공 차단층 및 전자 차단층에서 선택되는 1층 이상을 더 포함할 수 있다. 여기서 제2 전극은 반투과형 전극 또는 반사형 전극일 수 있고, 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다. 또한, 상기 정공 주입층은 p-도판트를, 상기 전자 주입층은 n-도판트를 추가로 도핑할 수 있다.One of the first electrode and the second electrode may be an anode and the other may be a cathode. The organic layer includes a light emitting layer and is selected from a hole injection layer, a hole transport layer, a hole auxiliary layer, a light emission auxiliary layer, an electron transport layer, an electron buffer layer, an electron injection layer, an interlayer, a hole blocking layer and an electron blocking layer. It may further comprise one or more layers. Here, the second electrode may be a transflective electrode or a reflective electrode, and may be a top emission type, a bottom emission type, or a double emission type depending on the material. In addition, the hole injection layer may further dop the p- dopant, the electron injection layer may be further doped with the n- dopant.
본원에 따른 유기 전계 발광 소자는 애노드, 캐소드 및 상기 애노드와 상기 캐소드 사이에 적어도 1층의 유기물층을 포함하고, 상기 유기물층은 제1 유기 전계 발광 재료 및 제2 유기 전계 발광 재료로 상기 화학식 1로 표시되는 서로 다른 화합물을 포함하는 복수 종의 유기 전계 발광 재료를 포함할 수 있다. 본원에 따른 유기 전계 발광 소자는 애노드, 캐소드, 및 상기 애노드와 상기 캐소드 사이에 적어도 1층의 발광층을 포함하고, 상기 발광층은 화학식 1로 표시되는 서로 다른 둘 이상의 화합물을 포함할 수 있다.The organic electroluminescent device according to the present invention includes an anode, a cathode, and at least one organic material layer between the anode and the cathode, wherein the organic material layer is represented by Chemical Formula 1 as the first organic electroluminescent material and the second organic electroluminescent material. It may include a plurality of types of organic electroluminescent materials including different compounds. The organic electroluminescent device according to the present application includes an anode, a cathode, and at least one light emitting layer between the anode and the cathode, and the light emitting layer may include two or more different compounds represented by Chemical Formula 1.
상기 발광층은 호스트와 도판트를 포함하고, 상기 호스트는 복수종의 호스트 재료를 포함하며, 상기 화학식 1로 표시되는 화합물이 복수종의 호스트 재료 중 제1 및 제2 호스트 화합물로 포함될 수 있다. 여기서, 제1 호스트 화합물과 제 2 호스트 화합물의 중량비는 약 1:99 내지 약 99:1, 바람직하게는 약 10:90 내지 약 90:10, 더욱 바람직하게는 약 30:70 내지 약 70:30, 더욱 바람직하게는 약 40:60 내지 약 60:40이며, 더욱 더 바람직하게는 약 50:50이다.The emission layer may include a host and a dopant, and the host may include a plurality of host materials, and the compound represented by Formula 1 may be included as the first and second host compounds among the plurality of host materials. Wherein the weight ratio of the first host compound to the second host compound is from about 1:99 to about 99: 1, preferably from about 10:90 to about 90:10, more preferably from about 30:70 to about 70:30 , More preferably about 40:60 to about 60:40, even more preferably about 50:50.
본원에서 발광층은 발광이 이루어지는 층으로서 단일층일 수 있으며, 또한 2개 이상의 층이 적층된 복수의 층일 수 있다. 본원의 복수 종의 호스트 재료는 제1 및 제2 호스트 재료가 모두 하나의 층에 포함될 수도 있고, 제1 및 제2 호스트 재료가 각각 다른 발광층에 포함될 수도 있다. 본원의 일 태양에 따르면, 상기 발광층의 호스트 화합물에 대한 도판트 화합물의 도핑 농도는 20 중량% 미만일 수 있다.The light emitting layer may be a single layer as a light emitting layer, and may be a plurality of layers in which two or more layers are stacked. In the plurality of types of host materials herein, both the first and second host materials may be included in one layer, and the first and second host materials may be included in different light emitting layers, respectively. According to one aspect of the present application, the doping concentration of the dopant compound with respect to the host compound of the light emitting layer may be less than 20% by weight.
본원의 유기 전계 발광 소자는 정공주입층, 정공전달층, 정공보조층, 발광보조층, 전자전달층, 전자주입층, 계면층(interlayer), 전자버퍼층, 정공차단층 및 전자차단층에서 선택되는 1층 이상을 더 포함할 수 있다. 본원의 일 양태에 따르면, 본원의 유기 전계 발광 소자는 본원의 복수 종의 호스트 재료 이외에 아민계 화합물을 정공 주입 재료, 정공 전달 재료, 정공 보조 재료, 발광 재료, 발광 보조 재료, 및 전자 차단 재료 중 하나 이상으로 더 포함할 수 있다. 또한, 본원의 일 양태에 따르면, 본원의 유기 전계 발광 소자는 본원의 복수 종의 호스트 재료 이외에 아진계 화합물을 전자 전달 재료, 전자 주입 재료, 전자 버퍼 재료 및 정공 차단 재료 중 하나 이상으로 더 포함할 수 있다.The organic electroluminescent device of the present application is selected from a hole injection layer, a hole transport layer, a hole auxiliary layer, a light emitting auxiliary layer, an electron transport layer, an electron injection layer, an interlayer, an electron buffer layer, a hole blocking layer and an electron blocking layer It may further comprise one or more layers. According to an aspect of the present application, the organic electroluminescent device of the present application is a amine-based compound in addition to the plurality of host materials of the present application of the hole injection material, hole transport material, hole auxiliary material, light emitting material, light emission auxiliary material, and electron blocking material One or more may be included. In addition, according to an aspect of the present disclosure, the organic electroluminescent device of the present application may further include a azine compound as one or more of an electron transport material, an electron injection material, an electron buffer material, and a hole blocking material in addition to the plurality of host materials of the present application. Can be.
본원의 유기 전계 발광 소자에 포함되는 도판트로는 하나 이상의 인광 또는 형광 도판트를 사용할 수 있고, 인광 도판트가 바람직하다. 본원의 유기 전계 발광 소자에 적용되는 인광 도판트 재료는 특별히 제한되지는 않으나, 이리듐(Ir), 오스뮴(Os), 구리(Cu) 및 백금(Pt)으로부터 선택되는 금속 원자의 착체 화합물일 수 있고, 경우에 따라 바람직하게는, 이리듐(Ir), 오스뮴(Os), 구리(Cu) 및 백금(Pt)으로부터 선택되는 금속 원자의 오르토 메탈화 착체 화합물일 수 있으며, 경우에 따라 더 바람직하게는, 오르토 메탈화 이리듐 착체 화합물일 수 있다.As the dopant included in the organic electroluminescent device of the present application, one or more phosphorescent or fluorescent dopants may be used, and a phosphorescent dopant is preferable. The phosphorescent dopant material applied to the organic electroluminescent device of the present application is not particularly limited, but may be a complex compound of a metal atom selected from iridium (Ir), osmium (Os), copper (Cu) and platinum (Pt) , In some cases, preferably, ortho-metalized complex compounds of metal atoms selected from iridium (Ir), osmium (Os), copper (Cu) and platinum (Pt), and more preferably in some cases, Ortho-metalized iridium complex compounds.
본원의 유기 전계 발광 소자에 포함되는 도판트로 하기 화학식 101로 표시되는 화합물을 사용할 수 있으나, 이에 한정되지는 않는다.As a dopant included in the organic electroluminescent device of the present application, a compound represented by the following Formula 101 may be used, but is not limited thereto.
[화학식 101][Formula 101]
상기 화학식 101에서,In Chemical Formula 101,
L은 하기 구조 1 또는 2에서 선택되고;L is selected from structures 1 or 2 below;
[구조 1] [구조 2][Structure 1] [Structure 2]
R100 내지 R103은 각각 독립적으로 수소, 중수소, 할로겐, 할로겐으로 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C3-C30)시클로알킬, 치환 또는 비치환된 (C6-C30)아릴, 시아노, 치환 또는 비치환된 (3-30원)헤테로아릴, 또는 치환 또는 비치환된 (C1-C30)알콕시이거나; 인접한 치환기와 연결되어 고리를 형성할 수 있고, 예를 들면 피리딘과 함께 치환 또는 비치환된 퀴놀린, 치환 또는 비치환된 벤조푸로피리딘, 치환 또는 비치환된 벤조티에노피리딘, 치환 또는 비치환된 벤조티에노퀴놀린, 또는 치환 또는 비치환된 인데노퀴놀린 형성이 가능하며;R 100 to R 103 are each independently hydrogen, deuterium, halogen, (C1-C30) alkyl substituted or unsubstituted, substituted or unsubstituted (C3-C30) cycloalkyl, substituted or unsubstituted (C6- C30) aryl, cyano, substituted or unsubstituted (3- to 30-membered) heteroaryl, or substituted or unsubstituted (C1-C30) alkoxy; Can be linked to adjacent substituents to form a ring, for example substituted or unsubstituted quinoline with pyridine, substituted or unsubstituted benzofuropyridine, substituted or unsubstituted benzothienopyridine, substituted or unsubstituted benzo Thienoquinoline, or substituted or unsubstituted indenoquinoline formation is possible;
R104 내지 R107은 각각 독립적으로 수소, 중수소, 할로겐, 할로겐으로 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C3-C30)시클로알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (3-30원)헤테로아릴, 시아노, 또는 치환 또는 비치환된 (C1-C30)알콕시이거나; 인접한 치환기와 연결되어 고리를 형성할 수 있고, 예를 들면 벤젠과 함께 치환 또는 비치환된 나프틸, 치환 또는 비치환된 플루오렌, 치환 또는 비치환된 디벤조티오펜, 치환 또는 비치환된 디벤조푸란, 치환 또는 비치환된 인데노피리딘, 치환 또는 비치환된 벤조푸로피리딘, 또는 치환 또는 비치환된 벤조티에노피리딘 형성이 가능하며;R 104 to R 107 are each independently hydrogen, deuterium, halogen, (C1-C30) alkyl substituted or unsubstituted, substituted or unsubstituted (C3-C30) cycloalkyl, substituted or unsubstituted (C6- C30) aryl, substituted or unsubstituted (3- to 30-membered) heteroaryl, cyano, or substituted or unsubstituted (C1-C30) alkoxy; May be linked to adjacent substituents to form a ring, for example substituted or unsubstituted naphthyl, substituted or unsubstituted fluorene, substituted or unsubstituted dibenzothiophene, substituted or unsubstituted dialkyl with benzene Benzofuran, substituted or unsubstituted indenopyridine, substituted or unsubstituted benzofuropyridine, or substituted or unsubstituted benzothienopyridine is possible;
R201 내지 R211은 각각 독립적으로 수소, 중수소, 할로겐, 할로겐으로 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C3-C30)시클로알킬, 또는 치환 또는 비치환된 (C6-C30)아릴이거나; 인접 치환기와 연결되어 고리를 형성할 수 있으며;R 201 to R 211 are each independently hydrogen, deuterium, halogen, (C1-C30) alkyl unsubstituted or substituted with halogen, substituted or unsubstituted (C3-C30) cycloalkyl, or substituted or unsubstituted (C6 -C30) aryl; May be linked to an adjacent substituent to form a ring;
n은 1 내지 3의 정수이다.n is an integer of 1-3.
구체적으로, 상기 도판트 화합물의 구체적인 예는 다음과 같으나, 이에 한정되지는 않는다.Specifically, specific examples of the dopant compound are as follows, but are not limited thereto.
본원의 유기 전계 발광 소자에 있어서, 애노드와 발광층 사이에 정공주입층, 정공전달층, 또는 전자차단층에서 선택되거나 이들의 조합으로 이루어진 층이 사용될 수 있다. 정공주입층은 애노드에서 정공전달층 또는 전자차단층으로의 정공주입 장벽(또는 정공주입 전압)을 낮출 목적으로 복수의 층이 사용될 수 있으며, 각 층은 2개의 화합물이 동시에 사용될 수 있다. 정공전달층 또는 전자차단층도 복수의 층이 사용될 수 있다.In the organic electroluminescent device of the present application, a layer selected from a hole injection layer, a hole transport layer, an electron blocking layer, or a combination thereof may be used between the anode and the light emitting layer. As the hole injection layer, a plurality of layers may be used for the purpose of lowering the hole injection barrier (or hole injection voltage) from the anode to the hole transport layer or the electron blocking layer, and two layers may be used at the same time. A plurality of layers may also be used for the hole transport layer or the electron blocking layer.
또한, 발광층과 캐소드 사이에 전자버퍼층, 정공차단층, 전자전달층, 또는 전자주입층에서 선택되거나 이들의 조합으로 이루어진 층이 사용될 수 있다. 전자버퍼층은 전자주입을 조절하고 발광층과 전자주입층 사이의 계면 특성을 향상시킬 목적으로 복수의 층이 사용될 수 있으며, 각 층은 2개의 화합물이 동시에 사용될 수 있다. 정공차단층 또는 전자전달층도 복수의 층이 사용될 수 있고, 각 층에 복수의 화합물이 사용될 수 있다.In addition, a layer selected from an electron buffer layer, a hole blocking layer, an electron transport layer, or an electron injection layer or a combination thereof may be used between the light emitting layer and the cathode. As the electron buffer layer, a plurality of layers may be used for controlling electron injection and improving interface characteristics between the light emitting layer and the electron injection layer, and two layers may be used simultaneously for each layer. A plurality of layers may be used for the hole blocking layer or the electron transfer layer, and a plurality of compounds may be used for each layer.
또한, 본원에 따른 유기 전계 발광 화합물 또는 복수 종의 호스트 재료는 양자점(QD)을 포함하는 유기 전계 발광 소자에도 사용될 수 있다.In addition, the organic electroluminescent compound or a plurality of host materials according to the present application can also be used in organic electroluminescent devices including quantum dots (QD).
본원의 유기 전계 발광 소자의 각 층은 진공 증착, 스퍼터링, 플라즈마, 이온 플레이팅 등의 건식 성막법이나, 잉크 젯 프린팅(ink jet printing), 노즐 프린팅(nozzle printing), 슬롯 코팅(slot coating), 스핀 코팅, 침지 코팅(dip coating), 플로우 코팅 등의 습식 성막법 중 어느 하나의 방법으로 형성될 수 있다. Each layer of the organic electroluminescent device of the present application is a dry film forming method such as vacuum deposition, sputtering, plasma, ion plating, ink jet printing, nozzle printing, slot coating, It may be formed by any one of wet film formation methods such as spin coating, dip coating, and flow coating.
습식 성막법의 경우, 각 층을 형성하는 재료를 에탄올, 클로로포름, 테트라하이드로푸란, 디옥산 등의 적절한 용매에 용해 또는 분산시켜 박막을 형성하는데, 그 용매는 각 층을 형성하는 재료가 용해 또는 분산될 수 있고, 성막성에 문제가 없는 것이라면 어느 것이어도 된다.In the case of the wet film formation method, a thin film is formed by dissolving or dispersing the material forming each layer in a suitable solvent such as ethanol, chloroform, tetrahydrofuran, dioxane, etc., in which the solvent is dissolved or dispersed. As long as there is no problem in film-forming property, it may be any.
또한, 본원의 제1 및 제2 호스트 화합물을 상기 열거된 방법으로 성막할 수 있으며, 흔히 공증착 또는 혼합증착 공정에 의해 성막할 수 있다. 상기 공증착은 두 가지 이상의 재료를 각각의 개별 도가니 소스에 넣고, 두 셀을 동시에 전류를 인가하여 재료를 증발시켜 혼합 증착하는 방식이고, 상기 혼합 증착은 증착 전 두 가지 이상의 재료를 하나의 도가니 소스에 혼합한 후, 하나의 셀에 전류를 인가하여 재료를 증발시켜 혼합 증착하는 방식이다. 또한, 제1 및 제2 호스트 화합물이 유기 전계 발광 소자 내의 같은 층 또는 다른 층에 존재하게 되는 경우, 두 호스트 화합물은 각각 개별적으로 성막할 수도 있다. 예를 들어, 제1 호스트 화합물을 증착한 후 제2 호스트 화합물을 증착할 수 있다.In addition, the first and second host compounds of the present application can be formed by the methods listed above, and can often be formed by a co-deposition or mixed deposition process. The co-deposition is a method in which two or more materials are put in each individual crucible source, and two cells are simultaneously applied to evaporate the material by evaporating the material, and the mixed deposition is one or more crucible sources before deposition. After mixing in, a current is applied to one cell to evaporate the material and vapor deposition. In addition, when the first and second host compounds are present in the same layer or in different layers in the organic electroluminescent device, the two host compounds may be deposited separately. For example, the second host compound may be deposited after the first host compound is deposited.
본원은 상기 화학식 1 로 표시되는 서로 다른 둘 이상의 화합물을 포함하는 복수 종의 호스트 재료를 이용하여 디스플레이 장치를 제공할 수 있다. 또한, 본원의 유기 전계 발광 소자를 이용하여 표시 장치 또는 조명 장치를 제조하는 것이 가능하다. 구체적으로, 본원의 유기 전계 발광 소자를 이용하여 디스플레이 장치, 예를 들면, 스마트폰, 태블릿, 노트북, PC, TV 또는 차량용의 디스플레이 장치, 또는 조명 장치, 예를 들면, 옥외 또는 옥내용 조명 장치를 제조하는 것이 가능하다.The present application may provide a display device using a plurality of types of host materials including two or more different compounds represented by Formula 1 above. In addition, it is possible to manufacture a display device or a lighting device using the organic electroluminescent element of the present application. Specifically, a display device, for example, a display device for a smartphone, a tablet, a notebook, a PC, a TV, or a vehicle, or a lighting device, for example, an outdoor or indoor lighting device, using the organic electroluminescent element of the present application. It is possible to manufacture.
이하에서, 본원의 상세한 이해를 위하여 본원의 대표 화합물을 들어 본원에 따른 화합물의 제조방법 및 이의 물성, 그리고 본원의 복수 종의 호스트 재료를 포함하는 OLED 소자의 특성에 대해 살펴본다. 그러나, 이하의 실시예는 본원의 상세한 이해를 위하여 본원에 따른 화합물 및 본원에 따른 복수 종의 호스트 재료를 포함하는 OLED 소자의 특성을 설명한 것일 뿐, 본원은 하기의 예들에 한정되는 것은 아니다.In the following, for a detailed understanding of the present application, a representative compound of the present application will be described for the preparation method of the compound according to the present invention and its physical properties, and the characteristics of the OLED device comprising a plurality of host materials of the present application. However, the following examples merely illustrate the characteristics of an OLED device comprising a compound according to the present application and a plurality of host materials according to the present application for the detailed understanding of the present application, and the present application is not limited to the following examples.
[[ 실시예Example 1] 화합물 C-8의 제조 1] Preparation of Compound C-8
1) 화합물 1의 합성1) Synthesis of Compound 1
플라스크에 2-니트로-1-나프톨 (70 g, 370 mmol), 4-(다이메틸아미노)피리딘 (DMAP) (4.5 g, 37 mmol), 및 메틸렌 클로라이드 (MC) 1800 mL를 넣어 녹인 후, 트리에틸아민 (TEA) (62 mL, 444 mmol)을 0℃에서 적가한 뒤, 20분 동안 교반시킨다. 반응물에 트리플루오로메탄술폰산무수물 (125.3 g, 444 mmol)을 동일 온도에서 천천히 적가한 뒤 1시간 동안 교반시켰다. 반응이 끝나면 MC로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 1 (96.2 g, 수율: 81%)을 얻었다.To the flask was dissolved 2-nitro-1-naphthol (70 g, 370 mmol), 4- (dimethylamino) pyridine (DMAP) (4.5 g, 37 mmol), and 1800 mL of methylene chloride (MC). Ethylamine (TEA) (62 mL, 444 mmol) is added dropwise at 0 ° C. and stirred for 20 minutes. Trifluoromethanesulfonic anhydride (125.3 g, 444 mmol) was slowly added dropwise to the reaction at the same temperature, followed by stirring for 1 hour. After the reaction, the organic layer was extracted with MC and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 1 (96.2 g, yield: 81%).
2) 화합물 2의 합성2) Synthesis of Compound 2
플라스크에 화합물 1 (96.2 g, 299 mmol), 2-브로모페닐보론산 (72.1 g, 359 mmol), 테트라키스(트리페닐포스핀)팔라듐(0) (17.3 g, 15 mmol), 탄산나트륨 (79.3 g, 749 mmol), 톨루엔 1400 mL, 에탄올 350 mL 및 물 350 mL를 넣어 녹인 후 1시간 동안 환류시켰다. 반응이 끝나면 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 2 (98 g, 수율: 99%)을 얻었다.Flask compound 1 (96.2 g, 299 mmol), 2-bromophenylboronic acid (72.1 g, 359 mmol), tetrakis (triphenylphosphine) palladium (0) (17.3 g, 15 mmol), sodium carbonate (79.3 g, 749 mmol), 1400 mL of toluene, 350 mL of ethanol, and 350 mL of water were dissolved and refluxed for 1 hour. After the reaction, the organic layer was extracted with ethyl acetate, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 2 (98 g, yield: 99%).
3) 화합물 3의 합성3) Synthesis of Compound 3
플라스크에 화합물 2 (98 g, 299 mmol), 2-아미노페닐보론산피나콜에스테르 (78.5 g, 358 mmol), 테트라키스(트리페닐포스핀)팔라듐(0) (17.2 g, 15 mmol), 탄산칼륨 (103 g, 747 mmol), 톨루엔 1300 mL, 에탄올 350 mL 및 물 350 mL를 넣어 녹인 후 20시간 동안 환류시켰다. 반응이 끝나면 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 3 (54 g, 수율: 53%)을 얻었다.Flask compound 2 (98 g, 299 mmol), 2-aminophenylboronic acid pinacol ester (78.5 g, 358 mmol), tetrakis (triphenylphosphine) palladium (0) (17.2 g, 15 mmol), carbonic acid Potassium (103 g, 747 mmol), 1300 mL of toluene, 350 mL of ethanol and 350 mL of water were added thereto, and the mixture was refluxed for 20 hours. After the reaction, the organic layer was extracted with ethyl acetate, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 3 (54 g, yield: 53%).
4) 화합물 4의 합성4) Synthesis of Compound 4
플라스크에 화합물 3 (25 g, 73 mmol), 아세트산 250 mL 및 황산 25 mL를 넣어 녹인 후 0℃에서 아질산나트륨 (6.5 g, 95 mmol)을 천천히 적가한 뒤, 40분 동안 교반시켰다. 반응이 끝나면 반응물을 물에 적가한 뒤 필터하여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 4 (2 g, 수율: 8.4%)을 얻었다.Compound 3 (25 g, 73 mmol), 250 mL of acetic acid and 25 mL of sulfuric acid were dissolved in the flask, and sodium nitrite (6.5 g, 95 mmol) was slowly added dropwise at 0 ° C., followed by stirring for 40 minutes. After the reaction, the reactants were added dropwise into water and filtered to remove moisture. Then dried and separated by column chromatography to give compound 4 (2 g, yield: 8.4%).
5) 화합물 5의 합성5) Synthesis of Compound 5
플라스크에 화합물 4 (4.7 g, 15 mmol), 트리에틸포스파이트 48 mL 및 1,2-디클로로벤젠 48 mL를 넣어 녹인 후 3시간 동안 환류시켰다. 반응이 끝나면 감압증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 5 (2.7 g, 수율: 63%)을 얻었다.Compound 4 (4.7 g, 15 mmol), 48 mL of triethylphosphite and 48 mL of 1,2-dichlorobenzene were dissolved in the flask, and the mixture was refluxed for 3 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 5 (2.7 g, yield: 63%).
6) 화합물 C-8의 합성6) Synthesis of Compound C-8
플라스크에 화합물 5 (2.1 g, 7 mmol), 2-(3-브로모페닐)-4,6-디페닐-1,3,5-트리아진 (3.1 g, 8 mmol), 아세트산 팔라듐(Ⅱ) (0.81 g, 0.36 mmol), 2-디사이클로헥실포스피노-2',6'-디메톡시바이페닐 (S-Phos) (0.3 g, 0.7 mmol), 소듐 tert-부톡사이드 (1.7 g, 18 mmol), 및 1,2-자일렌 72 mL를 넣어 녹인 후, 4시간 동안 환류시켰다. 반응이 끝나면 감압증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-8 (2.5 g, 수율: 58%)을 얻었다.Flask compound 5 (2.1 g, 7 mmol), 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8 mmol), palladium (II) acetate (0.81 g, 0.36 mmol), 2-dicyclohexylphosphino-2 ', 6'-dimethoxybiphenyl (S-Phos) (0.3 g, 0.7 mmol), sodium tert -butoxide (1.7 g, 18 mmol) ), And 72 mL of 1,2-xylene were dissolved and refluxed for 4 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-8 (2.5 g, yield: 58%).
[[ 실시예Example 2] 화합물 C-301의 제조 2] Preparation of Compound C-301
플라스크에 화합물 5 (5.0 g, 17 mmol), 2-([1,1'-바이페닐]-4-일)-4-클로로-6-페닐-1,3,5-트리아진 (7.08 g, 21 mmol), DMAP (105 mg, 0.858 mmol), 포타슘 카보네이트 (7.1 g, 51 mmol), 및 다이메틸포름아마이드(DMF) (85 mL)를 넣어 녹인 후, 3시간 동안 환류시켰다. 반응이 끝나면 감압 증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고 컬럼 크로마토그래피로 분리하여 화합물 C-301 (4.8 g, 수율: 47%)을 얻었다.In a flask, Compound 5 (5.0 g, 17 mmol), 2-([1,1'-biphenyl] -4-yl) -4-chloro-6-phenyl-1,3,5-triazine (7.08 g, 21 mmol), DMAP (105 mg, 0.858 mmol), potassium carbonate (7.1 g, 51 mmol), and dimethylformamide (DMF) (85 mL) were dissolved and refluxed for 3 hours. After the reaction, the organic layer was extracted with ethyl acetate after distillation under reduced pressure, and residual water was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-301 (4.8 g, yield: 47%).
[[ 실시예Example 3] 화합물 C-10의 제조 3] Preparation of Compound C-10
플라스크에 화합물 5 (5.0 g, 17 mmol), 2-(4-브로모나프탈렌-1-일)-4,6-디페닐-1,3,5-트리아진) (11.28 g, 21 mmol), 트리스(디벤질리덴아세톤)디팔라듐(0) (625 mg, 0.686 mmol), S-Phos (565 mg, 1 mmol), 소듐 tert-부톡사이드 (4.9 g, 51 mmol) 및 o-자일렌 (100 mL)를 넣어 녹인 후, 3시간 동안 환류시켰다. 반응이 끝나면 감압 증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-10 (3.6 g, 수율: 32%)을 얻었다. In a flask compound 5 (5.0 g, 17 mmol), 2- (4-bromonaphthalen-1-yl) -4,6-diphenyl-1,3,5-triazine) (11.28 g, 21 mmol), Tris (dibenzylideneacetone) dipalladium (0) (625 mg, 0.686 mmol), S-Phos (565 mg, 1 mmol), sodium tert -butoxide (4.9 g, 51 mmol) and o-xylene (100 mL) was dissolved and refluxed for 3 hours. After the reaction, the organic layer was extracted with ethyl acetate after distillation under reduced pressure, and residual water was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-10 (3.6 g, yield: 32%).
[[ 실시예Example 4] 화합물 C-7의 제조 4] Preparation of Compound C-7
플라스크에 화합물 5 (5 g, 17.1 mmol), 2-클로로-4,6-다이페닐-1,3,5-트리아진 (5.5 g, 20.5 mmol), DMAP (0.1 g, 0.85 mmol), 포타슘 카보네이트 (7.1 g, 51.4 mmol), 및 DMF 85 mL를 넣어 녹인 후, 3시간 동안 환류시켰다. 반응이 끝나면 식힌 후, 메탄올과 물을 넣고 여과하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-7 (4.4 g, 수율: 49%)을 얻었다. Flask 5 (5 g, 17.1 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (5.5 g, 20.5 mmol), DMAP (0.1 g, 0.85 mmol), potassium carbonate (7.1 g, 51.4 mmol), and 85 mL of DMF were dissolved therein, followed by refluxing for 3 hours. After the reaction was cooled, the mixture was filtered with methanol and water. Then dried and separated by column chromatography to give the compound C-7 (4.4 g, yield: 49%).
[[ 실시예Example 5] 화합물 C-302의 제조 5] Preparation of Compound C-302
플라스크에 화합물 5 (4.5 g, 15.4 mmol), 2-클로로-4-(나프탈렌-2-일)퀴나졸린 (5.4 g, 18.5 mmol), DMAP (0.09 g, 0.7 mmol), 포타슘 카보네이트 (6.4 g, 46.3 mmol), 및 DMF 77 mL을 넣어 녹인 후, 1.5시간 동안 환류시켰다. 반응이 끝나면 여과한 후, 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-302 (7.5 g, 수율: 80%)을 얻었다.In a flask, Compound 5 (4.5 g, 15.4 mmol), 2-chloro-4- (naphthalen-2-yl) quinazolin (5.4 g, 18.5 mmol), DMAP (0.09 g, 0.7 mmol), potassium carbonate (6.4 g, 46.3 mmol), and 77 mL of DMF were dissolved and then refluxed for 1.5 hours. After the reaction was filtered, dried, and separated by column chromatography to give the compound C-302 (7.5 g, yield: 80%).
[[ 실시예Example 6] 화합물 C-9의 제조 6] Preparation of Compound C-9
플라스크에 화합물 5 (5.0 g, 17.16 mmol), 2-(4-브로모페닐)-4,6-디페닐-1,3,5-트리아진 (6.6 g, 17.16 mmol), 트리스(디벤질리덴아세톤)디팔라듐(0) (0.6 g, 0.686 mmol), S-Phos(0.7 g, 1.176 mmol), 소듐 tert-부톡사이드 (4.0 g, 42.9 mmol), 및 o-자일렌 90 mL를 넣어 녹인 후 4시간 동안 환류시켰다. 반응이 끝나면 감압증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-9 (6.2 g, 수율: 62%)을 얻었다.Flask compound 5 (5.0 g, 17.16 mmol), 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (6.6 g, 17.16 mmol), tris (dibenzylidene Acetone) dipalladium (0) (0.6 g, 0.686 mmol), S-Phos (0.7 g, 1.176 mmol), sodium tert -butoxide (4.0 g, 42.9 mmol), and 90 mL of o-xylene were dissolved. Reflux for 4 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-9 (6.2 g, yield: 62%).
[[ 실시예Example 7] 화합물 C-303의 제조 7] Preparation of Compound C-303
플라스크에 화합물 5 (4.3 g, 14.83 mmol), 6-클로로-2,4-디페닐퀴나졸린(4.7 g, 14.83 mmol), Pd2(dba)3 (0.5 g, 0.593 mmol), S-Phos (0.6 g, 1.483 mmol), 소듐 tert-부톡사이드 (3.6 g, 37.07 mmol), 및 o-자일렌 80 mL를 넣어 녹인 후 4시간 동안 환류시켰다. 반응이 끝나면 감압증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-303 (1.8 g, 수율: 21%)을 얻었다.In a flask, Compound 5 (4.3 g, 14.83 mmol), 6-chloro-2,4-diphenylquinazoline (4.7 g, 14.83 mmol), Pd 2 (dba) 3 (0.5 g, 0.593 mmol), S-Phos ( 0.6 g, 1.483 mmol), sodium tert -butoxide (3.6 g, 37.07 mmol), and 80 mL of o-xylene were dissolved and refluxed for 4 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-303 (1.8 g, yield: 21%).
[[ 실시예Example 8] 화합물 C-307의 제조 8] Preparation of Compound C-307
플라스크에 화합물 5 (5.4 g, 18.53 mmol), 2-클로로-3-나프틸퀴녹살린(4.5 g, 15.44 mmol), 포타슘 카보네이트 (2.1 g, 15.44 mmol), DMAP (0.9 g, 7.72 mmol), 및 DMF 80 mL를 넣어 녹인 후 4시간 동안 환류시켰다. 반응이 끝나면 상온으로 냉각하고 증류수를 넣었다. MC로 유기층을 추출하고 황산마그네슘으로 건조하였다. 이 후, 감압 증류하고 컬럼 크로마토그래피로 분리하여 화합물 C-307 (2.3 g, 수율: 47%)을 얻었다.In a flask, Compound 5 (5.4 g, 18.53 mmol), 2-chloro-3-naphthylquinoxaline (4.5 g, 15.44 mmol), potassium carbonate (2.1 g, 15.44 mmol), DMAP (0.9 g, 7.72 mmol), and 80 mL of DMF was added to dissolve and refluxed for 4 hours. After the reaction was cooled to room temperature and distilled water was added. The organic layer was extracted with MC and dried over magnesium sulfate. Thereafter, the resulting mixture was distilled under reduced pressure and separated by column chromatography to obtain Compound C-307 (2.3 g, yield: 47%).
[[ 실시예Example 9] 화합물 C-13의 제조 9] Preparation of Compound C-13
플라스크에 화합물 5 (4.0 g, 13.73 mmol), 2-클로로-3-페닐퀴녹살린 (4.0 g, 16.47 mmol), 포타슘 카보네이트 (3.8 g, 27.46 mmol), DMAP (0.84 g, 6.87 mmol), 및 DMF 68 mL를 넣어 녹인 후 18시간 동안 환류시켰다. 반응이 끝나면 상온으로 냉각하고 증류수를 넣었다. MC로 유기층을 추출하고 황산마그네슘으로 건조하였다. 이 후, 감압 증류하고 컬럼 크로마토그래피로 분리하여 화합물 C-13 (2.3 g, 수율: 33.8%)을 얻었다.Flask compound 5 (4.0 g, 13.73 mmol), 2-chloro-3-phenylquinoxaline (4.0 g, 16.47 mmol), potassium carbonate (3.8 g, 27.46 mmol), DMAP (0.84 g, 6.87 mmol), and DMF 68 mL was added to dissolve and refluxed for 18 hours. After the reaction was cooled to room temperature and distilled water was added. The organic layer was extracted with MC and dried over magnesium sulfate. Thereafter, the resulting mixture was distilled under reduced pressure and separated by column chromatography to obtain Compound C-13 (2.3 g, yield: 33.8%).
[[ 실시예Example 10] 화합물 C- 10] Compound C- 304 의304 of 제조 Produce
1) 화합물 10-1의 합성1) Synthesis of Compound 10-1
화합물 5 (9 g, 30.89 mmol), 1-브로모-3-아이오도벤젠 (10.6 g, 61.78 mmol), CuI (3 g, 15.44 mmol), EDA (1.8 g, 30.89 mmol), 및 K3PO4 (16.4 g, 77.22 mmol)에 톨루엔 155 mL을 투입한 후 하룻동안 환류 교반하였다. 반응 종결 후 실온으로 냉각한 뒤, 생성된 고체를 감압 여과하였다. 고체를 CHCl3 에 녹여 MC/Hex으로 컬럼 크로마토그래피로 분리하여 화합물 10-1 (10 g, 수율: 75%)를 얻었다.Compound 5 (9 g, 30.89 mmol), 1-bromo-3-iodobenzene (10.6 g, 61.78 mmol), CuI (3 g, 15.44 mmol), EDA (1.8 g, 30.89 mmol), and K 3 PO 4 155 mL of toluene was added to (16.4 g, 77.22 mmol), followed by stirring under reflux for one day. After the completion of the reaction, the mixture was cooled to room temperature, and the resulting solid was filtered under reduced pressure. CHCl 3 solid Was dissolved in and separated by column chromatography with MC / Hex to obtain compound 10-1 (10 g, yield: 75%).
2) 화합물 C-304의 합성2) Synthesis of Compound C-304
화합물 10-1 (5.7 g, 12.77 mmol), Pd(PPh3)4 (0.73 g, 0.638 mmol), 및 K2CO3 (3.5 g, 25.54 mmol)에 톨루엔 50 mL, EtOH 13 mL, 정제수 13 mL을 투입한 후 2시간 동안 환류 교반하였다. 반응 종결 후 실온으로 냉각한 뒤, 생성된 고체를 감압 여과하였다. 고체를 CHCl3에 녹여 MC/Hex으로 컬럼 크로마토그래피로 분리하여 화합물 C-304 (2.9 g, 수율: 43%)을 얻었다.Compound 10-1 (5.7 g, 12.77 mmol), Pd (PPh 3 ) 4 (0.73 g, 0.638 mmol), and K 2 CO 3 (3.5 g, 25.54 mmol) in 50 mL of toluene, 13 mL of EtOH, 13 mL of purified water After stirring, the mixture was stirred under reflux for 2 hours. After the completion of the reaction, the mixture was cooled to room temperature, and the resulting solid was filtered under reduced pressure. The solid was dissolved in CHCl 3 and separated by column chromatography with MC / Hex to obtain compound C-304 (2.9 g, yield: 43%).
[[ 실시예Example 11] 화합물 C-306의 제조 11] Preparation of Compound C-306
플라스크에 화합물 10-1 (5.0 g, 11.2 mmol), N-페닐-[1,1'-비페닐]-4-아민 (3.0 g, 12.3 mmol), Pd2(dba)3 (0.51 g, 0.56 mmol), S-Phos (0.46 g, 1.12 mmol), 소듐 tert-부톡사이드 (2.7 g, 28 mmol), 및 톨루엔 60 mL를 넣은 후 4시간 동안 환류시켰다. 반응이 끝나면 감압 증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-306 (2.3 g, 수율: 34%)을 얻었다.Flask compound 10-1 (5.0 g, 11.2 mmol), N-phenyl- [1,1'-biphenyl] -4-amine (3.0 g, 12.3 mmol), Pd 2 (dba) 3 (0.51 g, 0.56 mmol), S-Phos (0.46 g, 1.12 mmol), sodium tert -butoxide (2.7 g, 28 mmol), and 60 mL of toluene were added and refluxed for 4 hours. After the reaction, the organic layer was extracted with ethyl acetate after distillation under reduced pressure, and residual water was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-306 (2.3 g, yield: 34%).
[[ 실시예Example 12] 화합물 C-333의 제조 12] Preparation of Compound C-333
플라스크에 화합물 12 (2.6 g, 7.6 mmol), 2-(3-브로모페닐)-4,6-디페닐-1,3,5-트리아진 (2.95 g, 7.6 mmol), 트리스(디벤질리덴아세톤)디팔라듐 (0) (0.27 g, 0.3 mmol), 2-디시클로 헥실 포스피노-2',6'-디메톡시바이페닐 (0.3 g, 0.7 mmol), 나트륨-tert-부톡사이드 (1.8 g, 19 mmol), 및 1,2-디메틸벤젠 50 mL를 넣어 녹인 후, 12시간 동안 환류시켰다. 반응이 끝나면 감압증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-333 (1.9 g, 수율: 38%)을 얻었다.Flask compound 12 (2.6 g, 7.6 mmol), 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (2.95 g, 7.6 mmol), tris (dibenzylidene Acetone) dipalladium (0) (0.27 g, 0.3 mmol), 2-dicyclo hexyl phosphino-2 ', 6'-dimethoxybiphenyl (0.3 g, 0.7 mmol), sodium tert -butoxide (1.8 g , 19 mmol), and 50 mL of 1,2-dimethylbenzene were dissolved and refluxed for 12 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-333 (1.9 g, yield: 38%).
[[ 실시예Example 13] 화합물 C-372의 제조 13] Preparation of Compound C-372
1) 화합물 13-1의 합성1) Synthesis of Compound 13-1
플라스크에 화합물 5 (70 g, 240 mmol), N-브로모숙신이미드 (40.6 g, 255 mmol), 및 디메틸포름아마이드 1200 mL를 넣어 녹인 후, 3시간 동안 0℃에서 교반시켰다. 반응이 끝나면 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 13-1 (68 g, 수율: 76%)을 얻었다.Compound 5 (70 g, 240 mmol), N-bromosuccinimide (40.6 g, 255 mmol), and 1200 mL of dimethylformamide were dissolved in the flask, followed by stirring at 0 ° C. for 3 hours. After the reaction, the organic layer was extracted with ethyl acetate, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 13-1 (68 g, yield: 76%).
2) 화합물 13-2의 합성2) Synthesis of Compound 13-2
플라스크에 화합물 13-1 (47.3 g, 127 mmol), 비스(피나콜라토)디보론 (42 g, 166 mmol), 비스(트리페닐포스핀)팔라듐디클로라이드(Ⅱ) (4.5 g, 6.4 mmol), 아세트산칼륨 (25 g, 255 mmol), 및 1,4-디옥산 635 mL를 넣어 녹인 후, 4시간 동안 환류시켰다. 반응이 끝나면 감압증류 후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 13-2 (31.5 g, 수율: 59%)을 얻었다.Flask compound 13-1 (47.3 g, 127 mmol), bis (pinacolato) diboron (42 g, 166 mmol), bis (triphenylphosphine) palladium dichloride (II) (4.5 g, 6.4 mmol) , Potassium acetate (25 g, 255 mmol), and 635 mL of 1,4-dioxane were added to dissolve and refluxed for 4 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 13-2 (31.5 g, yield: 59%).
3) 화합물 13-3의 합성3) Synthesis of Compound 13-3
플라스크에 화합물 13-2 (4.5 g, 10.7 mmol), 1-브로모벤젠 (1.9 g, 11.85 mmol), 테트라키스(트리페닐포스핀)팔라듐(0) (0.63 g, 0.54 mmol), 탄산칼륨 (3.7 g, 26.95 mmol), 톨루엔 54 mL, 에탄올 13 mL, 및 물 13 mL를 넣어 녹인 후 12시간 동안 환류시켰다. 반응이 끝나면 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 13-3 (2.2 g, 수율: 56%)을 얻었다.In a flask, compound 13-2 (4.5 g, 10.7 mmol), 1-bromobenzene (1.9 g, 11.85 mmol), tetrakis (triphenylphosphine) palladium (0) (0.63 g, 0.54 mmol), potassium carbonate ( 3.7 g, 26.95 mmol), 54 mL of toluene, 13 mL of ethanol, and 13 mL of water were added thereto, and the mixture was refluxed for 12 hours. After the reaction, the organic layer was extracted with ethyl acetate, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 13-3 (2.2 g, yield: 56%).
4) 화합물 C-372의 합성4) Synthesis of Compound C-372
플라스크에 화합물 13-3 (2.2 g, 5.9 mmol), 2-클로로-3-페닐퀴녹살린 (1.58 g, 6.57 mmol), 탄산세슘 (3.89 g, 11.96 mmol), 4-디메틸아미노피리딘 (0.36 g, 2.99 mmol), 및 디메틸 일산화황 30 mL를 넣어 녹인 후 4시간 동안 100℃에서 교반시켰다. 반응이 끝나면 상온으로 냉각하고 증류수를 넣었다. 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-372 (2.9 g, 수율: 85%)을 얻었다.In a flask, Compound 13-3 (2.2 g, 5.9 mmol), 2-chloro-3-phenylquinoxaline (1.58 g, 6.57 mmol), cesium carbonate (3.89 g, 11.96 mmol), 4-dimethylaminopyridine (0.36 g, 2.99 mmol), and 30 mL of dimethyl sulfur monoxide were dissolved and stirred at 100 ° C. for 4 hours. After the reaction was cooled to room temperature and distilled water was added. The organic layer was extracted with ethyl acetate and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-372 (2.9 g, yield: 85%).
[[ 실시예Example 14] 화합물 C-334의 제조 14] Preparation of Compound C-334
1) 화합물 14-1의 합성1) Synthesis of Compound 14-1
플라스크에 화합물 13-2 (27 g, 64.7 mmol), 1-브로모-2-니트로벤젠 (14.4 g, 71.2 mmol), 테트라키스(트리페닐포스핀)팔라듐(0) (3.7 g, 3.2 mmol), 탄산칼륨 (22.4 g, 162 mmol), 톨루엔 320 mL, 에탄올 80 mL, 및 물 80 mL를 넣어 녹인 후 12시간 동안 환류시켰다. 반응이 끝나면 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 14-1 (26.7 g, 수율: 100%)을 얻었다.Flask compound 13-2 (27 g, 64.7 mmol), 1-bromo-2-nitrobenzene (14.4 g, 71.2 mmol), tetrakis (triphenylphosphine) palladium (0) (3.7 g, 3.2 mmol) , Potassium carbonate (22.4 g, 162 mmol), 320 mL of toluene, 80 mL of ethanol, and 80 mL of water were dissolved and refluxed for 12 hours. After the reaction, the organic layer was extracted with ethyl acetate, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 14-1 (26.7 g, yield: 100%).
2) 화합물 14-2의 합성2) Synthesis of Compound 14-2
플라스크에 화합물 14-1 (26.7 g, 64.7 mmol), 1-아이오도벤젠 (18 mL, 162 mmol), 요오드화제일구리 (18.5 g, 97 mmol), 에틸렌다이아민 (13 mL, 194 mmol), 인산칼륨 (27.4 g, 129 mmol), 및 톨루엔 325 mL를 넣어 녹인 후 2시간 동안 환류시켰다. 반응이 끝나면 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고 컬럼 크로마토그래피로 분리하여 화합물 14-2 (15.7 g, 수율: 49%)을 얻었다.Flask compound 14-1 (26.7 g, 64.7 mmol), 1-iodobenzene (18 mL, 162 mmol), cuprous iodide (18.5 g, 97 mmol), ethylenediamine (13 mL, 194 mmol), phosphoric acid Potassium (27.4 g, 129 mmol), and 325 mL of toluene were added to dissolve and refluxed for 2 hours. After the reaction, the organic layer was extracted with ethyl acetate, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 14-2 (15.7 g, yield: 49%).
3) 화합물 14-3의 합성3) Synthesis of Compound 14-3
플라스크에 화합물 14-2 (13.1 g, 26.8 mmol), 트리에틸포스파이트 180 mL, 및 1,2-다이클로로벤젠 180 mL 를 넣고, 200℃로 2시간 교반하였다. 반응이 끝나면 감압증류하여 용매를 제거한 후, 상온으로 냉각하고 헥산을 넣어 고체를 얻었다. 생성된 고체를 필터를 통하여 용매를 제거한 후 컬럼 크로마토그래피로 분리하여 화합물 14-3 (0.71 g, 수율: 5.8%)을 얻었다.To the flask was added Compound 14-2 (13.1 g, 26.8 mmol), 180 mL of triethylphosphite, and 180 mL of 1,2-dichlorobenzene, followed by stirring at 200 ° C. for 2 hours. After the reaction was completed by distillation under reduced pressure to remove the solvent, cooled to room temperature and hexane was added to obtain a solid. The resulting solid was removed by a solvent through a filter and then separated by column chromatography to obtain compound 14-3 (0.71 g, yield: 5.8%).
4) 화합물 C-4) Compound C- 334 의334 of 합성 synthesis
플라스크에 화합물 14-3 (0.71 g, 1.56 mmol), 2-클로로-3-페닐퀴녹살린 (0.45 g, 1.87 mmol), 탄산세슘 (1.01 g, 3.12 mmol), 4-디메틸아미노피리딘 (0.095 g, 0.78 mmol), 및 디메틸 일산화황 30 mL를 넣어 녹인 후 4시간 동안 100℃에서 교반시켰다. 반응이 끝나면 상온으로 냉각하고 증류수와 메탄올을 넣었다. 생성된 고체를 필터를 통하여 용매를 제거한 후 컬럼 크로마토 그래피로 분리하여 화합물 C-334 (0.50 g, 수율: 49%)을 얻었다.In a flask, Compound 14-3 (0.71 g, 1.56 mmol), 2-chloro-3-phenylquinoxaline (0.45 g, 1.87 mmol), cesium carbonate (1.01 g, 3.12 mmol), 4-dimethylaminopyridine (0.095 g, 0.78 mmol), and 30 mL of dimethyl sulfur monoxide were dissolved and stirred at 100 ° C. for 4 hours. After the reaction was cooled to room temperature and distilled water and methanol was added. The resulting solid was removed through a filter and then separated by column chromatography to obtain a compound C-334 (0.50 g, yield: 49%).
[[ 실시예Example 15] 화합물 C-197의 제조 15] Preparation of Compound C-197
1) 화합물 15-1의 합성1) Synthesis of Compound 15-1
플라스크에 화합물 13-1 (40 g, 108 mmol), (2-메틸티오페닐)보론산 (25.4 g, 153.5 mmol), 테트라키스(트리페닐포스핀)팔라듐(O) (6.26 g, 5.40 mmol), 탄산칼륨 (26.3 g, 272.0 mmol), 테트라하이드로푸란 536 mL 및 증류수 134 mL를 넣어 녹인 후 100℃에서 18시간 동안 환류시켰다. 반응이 끝나면 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고 컬럼 크로마토그래피로 분리하여 화합물 15-1 (40 g, 수율: 89%)을 얻었다.Flask compound 13-1 (40 g, 108 mmol), (2-methylthiophenyl) boronic acid (25.4 g, 153.5 mmol), tetrakis (triphenylphosphine) palladium (O) (6.26 g, 5.40 mmol) , Potassium carbonate (26.3 g, 272.0 mmol), 536 mL of tetrahydrofuran, and 134 mL of distilled water were dissolved and refluxed at 100 ° C. for 18 hours. After the reaction, the organic layer was extracted with ethyl acetate, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound 15-1 (40 g, yield: 89%).
2) 화합물 15-2의 합성2) Synthesis of Compound 15-2
플라스크에 화합물 15-1 (40 g, 96.8 mmol), 테트라하이드로푸란 400 mL, 아세트산 200 mL 및 34.5%의 과산화수소 (12.6 mL, 145.2 mmol)를 넣어 녹인 후 상온에서 20시간 동안 교반시켰다. 반응이 끝나면 혼합물을 농축시킨 후, 염화메틸렌과 탄산수소나트륨 수용액으로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거한 뒤 건조시켜 화합물 15-2 (42 g, 수율: 100%)을 얻었다.Compound 15-1 (40 g, 96.8 mmol), tetrahydrofuran 400 mL, acetic acid 200 mL and 34.5% hydrogen peroxide (12.6 mL, 145.2 mmol) were dissolved in the flask, followed by stirring at room temperature for 20 hours. After the reaction was completed, the mixture was concentrated, the organic layer was extracted with methylene chloride and aqueous sodium hydrogen carbonate solution, and residual water was removed using magnesium sulfate, followed by drying to obtain compound 15-2 (42 g, yield: 100%).
3) 화합물 15-3의 합성3) Synthesis of Compound 15-3
화합물 15-2 (42 g, 96.4 mmol)을 트리플루오로메탄술폰산 190 mL에 녹인 후 상온에서 3일 동안 교반시켰다. 반응이 끝나면 0℃에서 혼합물에 피리딘 50 mL와 1M NaOH 수용액을 넣어 pH를 7 내지 8로 맞춘 후, 100℃에서 1시간 동안 환류시켰다. 필터를 통하여 용매를 제거한 후 생성된 고체를 컬럼 크로마토그래피로 분리하여 화합물 15-3 (9.1 g, 수율: 24%)을 얻었다.Compound 15-2 (42 g, 96.4 mmol) was dissolved in 190 mL of trifluoromethanesulfonic acid, followed by stirring at room temperature for 3 days. After the reaction, 50 mL of pyridine and 1M NaOH aqueous solution were added to the mixture at 0 ° C. to adjust the pH to 7 to 8, and the mixture was refluxed at 100 ° C. for 1 hour. The solvent was removed through a filter, and the resulting solid was separated by column chromatography to obtain compound 15-3 (9.1 g, yield: 24%).
4) 화합물 C-4) Compound C- 197 의197 of 합성 synthesis
플라스크에 화합물 15-3 (4 g, 10.1 mmol), 2-클로로-3-페닐퀴녹살린 (3 g, 12.1 mmol), 탄산세슘 (6.6 g, 20.2 mmol), 4-디메틸아미노피리딘 (0.62 g, 5.1 mmol), 및 디메틸 일산화황 50 mL를 넣어 녹인 후 4시간 동안 100℃에서 교반시켰다. 반응이 끝나면 상온으로 냉각하고 증류수와 메탄올을 넣었다. 생성된 고체를 필터를 통하여 용매를 제거한 후 컬럼 크로마토그래피로 분리하여 화합물 C-197 (4.8 g, 수율: 79%)을 얻었다. In a flask, Compound 15-3 (4 g, 10.1 mmol), 2-chloro-3-phenylquinoxaline (3 g, 12.1 mmol), cesium carbonate (6.6 g, 20.2 mmol), 4-dimethylaminopyridine (0.62 g, 5.1 mmol), and 50 mL of dimethyl sulfur monoxide were dissolved and stirred at 100 ° C. for 4 hours. After the reaction was cooled to room temperature and distilled water and methanol was added. The resulting solid was removed by a solvent through a filter and then separated by column chromatography to obtain a compound C-197 (4.8 g, yield: 79%).
[[ 실시예Example 16] 화합물 C-339의 제조 16] Preparation of Compound C-339
1) 화합물 16-1의 합성1) Synthesis of Compound 16-1
화합물 5 (15.6 g, 53.5 mmol), 2,3-디클로로벤조[f]퀴녹살린 (20 g, 80.3 mmol), 탄산칼륨 (15 g, 107.0 mmol), N,N-디메틸-4-피리딘아민 (3.3 g, 26.7 mmol), 및 N,N-디메틸포름아미드 270 mL를 첨가한 후 150℃에서 4 시간 교반하였다. 반응이 끝나면 상온으로 냉각하고 회전증발기로 용매를 제거하였다. 이 후 컬럼 크로마토그래피로 분리하여 화합물 16-1 (2.2 g, 8%)를 얻었다.Compound 5 (15.6 g, 53.5 mmol), 2,3-dichlorobenzo [ f ] quinoxaline (20 g, 80.3 mmol), potassium carbonate (15 g, 107.0 mmol), N, N-dimethyl-4-pyridinamine ( 3.3 g, 26.7 mmol), and 270 mL of N, N-dimethylformamide were added, followed by stirring at 150 ° C. for 4 hours. After the reaction was cooled to room temperature and the solvent was removed by rotary evaporator. Then separated by column chromatography to give compound 16-1 (2.2 g, 8%).
2) 화합물 C-339의 합성2) Synthesis of Compound C-339
반응용기에 화합물 16-1 (2.2 g, 4.4 mmol), 페닐보론산 (800 mg, 6.6 mmol), 테트라키스(트라이페닐포스핀)팔라듐 (250 mg, 0.2 mmol), 탄산나트륨 (1.2 g, 10.9 mmol), 톨루엔 20 mL, 및 에탄올 5 mL를 첨가한 후 130℃에서 3 시간 교반하였다. 반응이 끝나면 상온으로 냉각하고 회전증발기로 용매를 제거하였다. 이 후 컬럼 크로마토그래피로 분리하여 화합물 C-339 (1.8 g, 76%)를 얻었다.Compound 16-1 (2.2 g, 4.4 mmol), phenylboronic acid (800 mg, 6.6 mmol), tetrakis (triphenylphosphine) palladium (250 mg, 0.2 mmol), sodium carbonate (1.2 g, 10.9 mmol) in the reaction vessel ), 20 mL of toluene, and 5 mL of ethanol were added, followed by stirring at 130 ° C. for 3 hours. After the reaction was cooled to room temperature and the solvent was removed by rotary evaporator. Thereafter, the residue was separated by column chromatography, obtaining a compound C-339 (1.8 g, 76%).
[[ 실시예Example 17] 화합물 C-338의 제조 17] Preparation of Compound C-338
1) 화합물 17-1의 합성1) Synthesis of Compound 17-1
화합물 5 (15.6 g, 53.5 mmol), 2,3-디클로로벤조[f]퀴녹살린 (20 g, 80.3 mmol), 탄산칼륨 (15 g, 107.0 mmol), N,N-디메틸-4-피리딘아민 (3.3 g, 26.7 mmol), 및 N,N-디메틸포름아미드 270 mL를 첨가한 후 150℃에서 4 시간 동안 교반시켰다. 반응이 끝나면 상온으로 냉각하고 회전증발기로 용매를 제거하였다. 이 후 컬럼 크로마토그래피로 분리하여 화합물 17-1 (2.8 g, 10%)를 얻었다.Compound 5 (15.6 g, 53.5 mmol), 2,3-dichlorobenzo [ f ] quinoxaline (20 g, 80.3 mmol), potassium carbonate (15 g, 107.0 mmol), N, N-dimethyl-4-pyridinamine ( 3.3 g, 26.7 mmol), and 270 mL of N, N-dimethylformamide were added and then stirred at 150 ° C. for 4 hours. After the reaction was cooled to room temperature and the solvent was removed by rotary evaporator. Thereafter, the residue was separated by column chromatography, obtaining a compound 17-1 (2.8 g, 10%).
2) 화합물 C-338의 합성2) Synthesis of Compound C-338
반응용기에 화합물 17-1 (2.7 g, 5.4 mmol), 페닐보론산 (1 g, 8.0 mmol), 테트라키스(트라이페닐포스핀)팔라듐 (310 mg, 0.3 mmol), 탄산나트륨 (1.4 g, 13.4 mmol), 톨루엔 28 mL, 및 에탄올 7 mL를 첨가한 후 130℃에서 3 시간 동안 교반시켰다. 반응이 끝나면 상온으로 냉각하고 회전증발기로 용매를 제거하였다. 이 후 컬럼 크로마토그래피로 분리하여 화합물 C-338 (2.5 g, 86%)를 얻었다.Compound 17-1 (2.7 g, 5.4 mmol), phenylboronic acid (1 g, 8.0 mmol), tetrakis (triphenylphosphine) palladium (310 mg, 0.3 mmol), sodium carbonate (1.4 g, 13.4 mmol) in the reaction vessel ), 28 mL of toluene, and 7 mL of ethanol were added and then stirred at 130 ° C. for 3 hours. After the reaction was cooled to room temperature and the solvent was removed by rotary evaporator. After separation by column chromatography to give the compound C-338 (2.5 g, 86%).
[[ 실시예Example 18] 18] 화합물 C-379의 제조Preparation of Compound C-379
플라스크에 화합물 5 (4.0 g, 13.73 mmol), 5-클로로-2,3-디페닐퀴녹살린 (5.2 g, 16.47 mmol), 트리스(디벤질리덴아세톤)디팔라듐(0) (0.629 g, 0.686 mmol), 2-디시클로헥실포스피노-2',6'-디메톡시바이페닐 (0.564 mg, 1.0 mmol), 나트륨-tert-부톡사이드 (3.9 g, 41 mmol), 및 1,2-디메틸벤젠 80 mL를 넣어 녹인 후 4시간 동안 환류시켰다. 반응이 끝나면 상온으로 냉각하고 증류수를 넣었다. MC로 유기층을 추출하고 마그네슘 설페이트로 건조하였다. 감압 증류하고 컬럼 크로마토그래피로 분리하여 화합물 C-379 (2.8 g, 수율: 35.67%)을 얻었다.Flask compound 5 (4.0 g, 13.73 mmol), 5-chloro-2,3-diphenylquinoxaline (5.2 g, 16.47 mmol), tris (dibenzylideneacetone) dipalladium (0) (0.629 g, 0.686 mmol ), 2-dicyclohexylphosphino-2 ', 6'-dimethoxybiphenyl (0.564 mg, 1.0 mmol), sodium tert -butoxide (3.9 g, 41 mmol), and 1,2-dimethylbenzene 80 After adding mL to dissolve and reflux for 4 hours. After the reaction was cooled to room temperature and distilled water was added. The organic layer was extracted with MC and dried over magnesium sulfate. Distillation under reduced pressure and separation by column chromatography gave Compound C-379 (2.8 g, yield: 35.67%).
[[ 실시예Example 19] 화합물 C-389의 제조 19] Preparation of Compound C-389
플라스크에 화합물 5 (6.0 g, 21 mmol), 2-([1,1'-바이페닐]-3-일)-3-클로로퀴녹살린 (7.8 g, 25 mmol), 탄산칼륨 (8.5 g, 62 mmol), 4-디메틸아미노피리딘 (0.126 g, 1 mmol), 디메틸포름아마이드 100 mL를 넣어 녹인 후 4시간 동안 환류시켰다. 반응이 끝나면 상온으로 냉각하고 증류수를 넣었다. MC로 유기층을 추출하고 마그네슘 설페이트로 건조하였다. 감압 증류하고 컬럼 크로마토그래피로 분리하여 화합물 C-389 (8.8 g, 수율: 74%)을 얻었다. Flask compound 5 (6.0 g, 21 mmol), 2-([1,1'-biphenyl] -3-yl) -3-chloroquinoxaline (7.8 g, 25 mmol), potassium carbonate (8.5 g, 62 mmol), 4-dimethylaminopyridine (0.126 g, 1 mmol), and 100 mL of dimethylformamide were added and dissolved at reflux for 4 hours. After the reaction was cooled to room temperature and distilled water was added. The organic layer was extracted with MC and dried over magnesium sulfate. Distillation under reduced pressure and separation by column chromatography gave Compound C-389 (8.8 g, yield: 74%).
[[ 실시예Example 20] 화합물 C-395의 제조 20] Preparation of Compound C-395
플라스크에 화합물 5 (7.9 g, 27 mmol), 2-클로로-3-(페닐-D5)퀴녹살린 (7.9 g, 33 mmol), 탄산칼륨 (11.24 g, 81 mmol), 4-디메틸아미노피리딘 (0.166 g, 1 mmol), 및 디메틸포름아마이드 135 mL를 넣어 녹인 후 4시간 동안 환류시켰다. 반응이 끝나면 상온으로 냉각하고 증류수를 넣었다. MC로 유기층을 추출하고 마그네슘 설페이트로 건조하였다. 감압 증류하고 컬럼 크로마토그래피로 분리하여 화합물 C-395 (3.2 g, 수율: 23.7%)을 얻었다. Flask compound 5 (7.9 g, 27 mmol), 2-chloro-3- (phenyl-D5) quinoxaline (7.9 g, 33 mmol), potassium carbonate (11.24 g, 81 mmol), 4-dimethylaminopyridine (0.166 g, 1 mmol), and 135 mL of dimethylformamide were dissolved and refluxed for 4 hours. After the reaction was cooled to room temperature and distilled water was added. The organic layer was extracted with MC and dried over magnesium sulfate. Distillation under reduced pressure and separation by column chromatography gave Compound C-395 (3.2 g, yield: 23.7%).
[[ 실시예Example 21] 화합물 C-380의 제조 21] Preparation of Compound C-380
플라스크에 화합물 5 (10 g, 28.82 mmol), 2-클로로-3-(4-(나프탈렌-2-일)페닐)퀴녹살린 (7.0 g, 24.02 mmol), 4-(다이메틸아미노)피리딘 (1.5 g, 12.01 mmol), 탄산칼륨 (3.3 g, 24.02 mmol), 및 디메틸포름아마이드 (130 mL)를 넣어 녹인 후 3시간 동안 환류시켰다. 반응이 끝나면 감압 증류후에 에틸 아세테이트로 유기층을 추출하고, 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-380 (8.8 g, 수율: 59%)을 얻었다.In a flask, Compound 5 (10 g, 28.82 mmol), 2-chloro-3- (4- (naphthalen-2-yl) phenyl) quinoxaline (7.0 g, 24.02 mmol), 4- (dimethylamino) pyridine (1.5 g, 12.01 mmol), potassium carbonate (3.3 g, 24.02 mmol), and dimethylformamide (130 mL) were added thereto, and the mixture was refluxed for 3 hours. After the reaction, the organic layer was extracted with ethyl acetate after distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound C-380 (8.8 g, yield: 59%).
[[ 실시예Example 22] 화합물 C-394의 제조 22] Preparation of Compound C-394
플라스크에 화합물 5 (6 g, 20.59 mmol), 2-(3-클로로퀴녹살린-2-일)-9-페닐-9H-카바졸 (9.1 g, 22.65 mmol), 4-(다이메틸아미노)피리딘 (1.2 g, 10.29 mmol), 탄산칼륨 (2.8 g, 20.59 mmol), 및 디메틸포름아마이드 (100 mL)를 넣어 녹인 후 3시간 동안 환류시켰다. 반응이 끝나면 감압 증류 후에 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-394 (9.6 g, 수율: 70%)을 얻었다.Flask compound 5 (6 g, 20.59 mmol), 2- (3-chloroquinoxalin-2-yl) -9-phenyl-9H-carbazole (9.1 g, 22.65 mmol), 4- (dimethylamino) pyridine (1.2 g, 10.29 mmol), potassium carbonate (2.8 g, 20.59 mmol), and dimethylformamide (100 mL) were added thereto, and the mixture was refluxed for 3 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound C-394 (9.6 g, yield: 70%).
[[ 실시예Example 23] 화합물 C-346의 제조 23] Preparation of Compound C-346
플라스크에 화합물 5 (6.0 g, 20.59 mmol), 2-(2-클로로퀴나졸린-4-일)-9-페닐-9H-카바졸 (9.1 g, 22.65 mmol), 4-(다이메틸아미노)피리딘 (1.2 g, 10.29 mmol), 탄산칼륨 (2.8 g, 20.59 mmol), 및 디메틸포름아마이드 (100 mL)를 넣어 녹인 후 3시간 동안 환류시켰다. 반응이 끝나면 감압 증류후에 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-346 (10 g, 수율: 77%)을 얻었다. Flask compound 5 (6.0 g, 20.59 mmol), 2- (2-chloroquinazolin-4-yl) -9-phenyl-9H-carbazole (9.1 g, 22.65 mmol), 4- (dimethylamino) pyridine (1.2 g, 10.29 mmol), potassium carbonate (2.8 g, 20.59 mmol), and dimethylformamide (100 mL) were added thereto, and the mixture was refluxed for 3 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-346 (10 g, yield: 77%).
[[ 실시예Example 24] 화합물 C-388의 제조 24] Preparation of Compound C-388
플라스크에 화합물 5 (12 g, 41.1 mmol), 2-(4-브로모페닐)-4-페닐퀴나졸린 (14.8 g, 41.1 mmol), 트리스(디벤질리덴아세톤)디팔라듐 (0) (1.5 g, 1.6 mmol), 2-디사이클로헥실포스피노-2'-6'-디메톡시바이페닐 (1.7 g, 4.1 mmol), 소듐 tert-부톡사이드 (9.8 g, 102.9 mmol) 및 자일렌 (274 mL)를 넣어 녹인 후 4시간 동안 환류시켰다. 반응이 끝나면 식힌 후, 컬럼 크로마토그래피로 분리하여 화합물 C-388 (1.1 g, 수율: 4.7%)을 얻었다. Flask compound 5 (12 g, 41.1 mmol), 2- (4-bromophenyl) -4-phenylquinazoline (14.8 g, 41.1 mmol), tris (dibenzylideneacetone) dipalladium (0) (1.5 g , 1.6 mmol), 2-dicyclohexylphosphino-2'-6'-dimethoxybiphenyl (1.7 g, 4.1 mmol), sodium tert -butoxide (9.8 g, 102.9 mmol) and xylene (274 mL) Melted and refluxed for 4 hours. After the reaction was completed, the mixture was cooled and separated by column chromatography, obtaining a compound C-388 (1.1 g, yield: 4.7%).
[[ 실시예Example 25] 화합물 C-381의 제조 25] Preparation of Compound C-381
플라스크에 화합물 5 (5.7 g, 19.5 mmol), 2-클로로-3-(다이벤조[b,d]퓨란-1-일)퀴녹살린 (7.7 g, 23.2 mmol), 4-(다이메틸아미노)피리딘 (0.1 g, 0.9 mmol), 탄산칼륨 (8.1 g, 58.5 mmol), 및 다이메틸포름아마이드 99 mL 를 넣어 녹인 후 3시간 30분 동안 환류시켰다. 반응이 끝나면 식힌 후, 메탄올과 물을 넣고 필터하였다. 이 후에 건조시키고 컬럼 크로마토그래피로 분리하여 화합물 C-381 (6 g, 수율: 52%)을 얻었다. Flask compound 5 (5.7 g, 19.5 mmol), 2-chloro-3- (dibenzo [b, d] furan-1-yl) quinoxaline (7.7 g, 23.2 mmol), 4- (dimethylamino) pyridine (0.1 g, 0.9 mmol), potassium carbonate (8.1 g, 58.5 mmol), and 99 mL of dimethylformamide were added thereto, and the resulting mixture was refluxed for 3 hours 30 minutes. After the reaction was cooled, the mixture was filtered with methanol and water. Then dried and separated by column chromatography to give compound C-381 (6 g, yield: 52%).
[[ 실시예Example 26] 화합물 C-378의 제조 26] Preparation of Compound C-378
플라스크에 화합물 5 (3.8 g, 13 mmol), 2-([1,1'-바이페닐]-4-일)-3-클로로퀴녹살린 (5.0 g, 16 mmol), DMAP (800 mg, 7 mmol), 탄산 칼륨 (3.6 g, 26 mmol), 및 디메틸포름아마이드 55 mL를 넣어 녹인 후 18시간 동안 환류시켰다. 반응이 끝나면 감압 증류 후에 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-378 (1.4 g, 수율: 19%)을 얻었다.Flask compound 5 (3.8 g, 13 mmol), 2-([1,1'-biphenyl] -4-yl) -3-chloroquinoxaline (5.0 g, 16 mmol), DMAP (800 mg, 7 mmol ), Potassium carbonate (3.6 g, 26 mmol), and 55 mL of dimethylformamide were added thereto, and the mixture was refluxed for 18 hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound C-378 (1.4 g, yield: 19%).
[[ 실시예Example 27] 화합물 C-386의 제조 27] Preparation of Compound C-386
플라스크에 화합물 5 (5.1 g, 17 mmol), 6-클로로-2,3-디페닐퀴녹살린 (5.0 g, 16 mmol), 트리스(디벤질리덴아세톤)디팔라듐 (0) (578 mg, 0.631 mmol), 2-디사이클로헥실포스피노-2'-6'-디메톡시바이페닐 (648 mg, 2 mmol), 소듐 tert-부톡사이드 (3.8 g, 39 mmol), 및 톨루엔 100 mL를 넣어 녹인 후 16시간 동안 환류시켰다. 반응이 끝나면 감압 증류후에 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-386 (7.6 g, 수율: 84%)을 얻었다. Flask compound 5 (5.1 g, 17 mmol), 6-chloro-2,3-diphenylquinoxaline (5.0 g, 16 mmol), tris (dibenzylideneacetone) dipalladium (0) (578 mg, 0.631 mmol ), 2-dicyclohexylphosphino-2'-6'-dimethoxybiphenyl (648 mg, 2 mmol), sodium tert -butoxide (3.8 g, 39 mmol), and 100 mL of toluene were dissolved to dissolve 16 It was refluxed for hours. After the reaction, the organic layer was extracted with distillation under reduced pressure, and residual moisture was removed using magnesium sulfate. Then dried and separated by column chromatography to give the compound C-386 (7.6 g, yield: 84%).
[[ 실시예Example 28] 화합물 C- 28] Compound C- 387 의Of 387 제조 Produce
화합물 10-1 (6.6 g, 14.78 mmol), 디벤조[b,d]퓨란-1-일-보론산 (3.4 g, 16.24 mmol), 테트라키스(트리페닐포스핀)팔라듐(0) (0.85 g, 0.739 mmol), 및 탄산칼륨 (4 g, 29.57 mmol)에 톨루엔 60 mL, 에탄올 15 mL, 및 정제수 15 mL 을 투입한 후 하룻동안 환류 교반하였다. 반응 종결 후 실온으로 냉각한 뒤 생성된 고체를 감압여과하였다. 고체를 CHCl3 에 녹여 MC/Hex으로 컬럼 크로마토그래피로 분리하여 화합물 C-387 (3.5 g, 수율: 45%)를 얻었다.Compound 10-1 (6.6 g, 14.78 mmol), dibenzo [b, d] furan-1-yl-boronic acid (3.4 g, 16.24 mmol), tetrakis (triphenylphosphine) palladium (0) (0.85 g , 0.739 mmol), and potassium carbonate (4 g, 29.57 mmol) were added with 60 mL of toluene, 15 mL of ethanol, and 15 mL of purified water, followed by stirring under reflux for one day. After completion of the reaction, the mixture was cooled to room temperature, and the resulting solid was filtered under reduced pressure. CHCl 3 solid Was dissolved in and separated by column chromatography with MC / Hex to obtain compound C-387 (3.5 g, yield: 45%).
[[ 실시예Example 29] 화합물 C-393의 제조 29] Preparation of Compound C-393
플라스크에 화합물 5 (4.4 g, 15.16 mmol), 9-클로로-6-페닐-6H-인돌로[2,3,b]퀴녹살린 (5.0 g, 15.16 mmol), 트리스(디벤질리덴아세톤)디팔라듐(0) (0.5 g, 0.606 mmol), 2-디시클로헥실포스피노-2',6'-디메톡시비페닐 (0.6 g, 1.516 mmol), 나트륨-tert-부톡사이드 (12 g, 37.90 mmol), 및 1,2-디메틸벤젠 100 mL를 넣어 녹인 후 4시간 동안 환류시켰다. 반응이 끝나면 감압증류 후에 에틸 아세테이트로 유기층을 추출하고 마그네슘 설페이트를 이용하여 잔여 수분을 제거하였다. 이 후 건조시키고, 컬럼 크로마토그래피로 분리하여 화합물 C-393 (1.9 g, 수율: 21%)을 얻었다.Flask compound 5 (4.4 g, 15.16 mmol), 9-chloro-6-phenyl-6H-indolo [2,3, b] quinoxaline (5.0 g, 15.16 mmol), tris (dibenzylideneacetone) dipalladium (0) (0.5 g, 0.606 mmol), 2-dicyclohexylphosphino-2 ', 6'-dimethoxybiphenyl (0.6 g, 1.516 mmol), sodium tert -butoxide (12 g, 37.90 mmol) , And 100 mL of 1,2-dimethylbenzene were dissolved and refluxed for 4 hours. After the reaction, the organic layer was extracted with ethyl acetate after distillation under reduced pressure, and residual water was removed using magnesium sulfate. Then dried and separated by column chromatography to give compound C-393 (1.9 g, yield: 21%).
[[ 실시예Example 30] 화합물 C-447의 제조 30] Preparation of Compound C-447
1) 화합물 30-1의 합성1) Synthesis of Compound 30-1
플라스크에 화합물 13-1 (8.0 g, 21.6 mmol), 4-요오도바이페닐 (12.1 g, 43.2 mmol), 트리스(디벤질리덴아세톤)디팔라듐(0) (1.0 g, 1.08 mmol), 트리-tert-부틸포스핀 (0.87 mL, 2.16 mmol 50% 톨루엔용액), 소디움 tert-부톡사이드 (5.2 g, 54.0 mmol), 및 톨루엔 216 mL를 넣고 18시간 동안 환류시켰다. 반응이 끝나면 반응용액을 상온으로 냉각하고 회전 증발기로 용매를 제거하였다. 이 후 컬럼 크로마토그래피로 분리하여 화합물 30-1 (7.5 g, 66%)을 얻었다.Flask compound 13-1 (8.0 g, 21.6 mmol), 4-iodobiphenyl (12.1 g, 43.2 mmol), tris (dibenzylideneacetone) dipalladium (0) (1.0 g, 1.08 mmol), tri- tert Butyl phosphine (0.87 mL, 2.16 mmol 50% toluene solution), sodium tert -butoxide (5.2 g, 54.0 mmol), and 216 mL of toluene were added and refluxed for 18 hours. After the reaction, the reaction solution was cooled to room temperature and the solvent was removed by a rotary evaporator. Then separated by column chromatography to give compound 30-1 (7.5 g, 66%).
2) 화합물 30-2의 합성2) Synthesis of Compound 30-2
플라스크에 화합물 30-1 (7.5 g, 14.4 mmol), 메틸 2-(4,4,5,5-테트라메틸-1,3,2-다이옥실보렌-2-일)벤조에이트 (4.5 g, 17.3 mmol), 팔라듐아세테이트 (Pd(OAc)2) (323 mg, 1.44 mmol), 리간드(2-다이사이클로헥실포스포늄-2',6'-다이메톡시비페닐) (1.2 g, 2.88 mmol), 탄산세슘 (14 g, 43.2 mmol), 자일렌 80 mL, 에탄올 40 mL 및 증류수 40 mL를 넣고 18시간 동안 환류 교반하였다. 상온으로 냉각시키고 증류수를 넣었다. MC로 유기층을 추출하고 마그네슘 설페이트로 건조시켰다. 감압 증류하고 컬럼 크로마토그래피로 분리하여 화합물 30-2 (2.2 g, 수율: 27%)을 얻었다.Flask compound 30-1 (7.5 g, 14.4 mmol), methyl 2- (4,4,5,5-tetramethyl-1,3,2-dioxylboren-2-yl) benzoate (4.5 g, 17.3 mmol), palladium acetate (Pd (OAc) 2 ) (323 mg, 1.44 mmol), ligand (2-dicyclohexylphosphonium-2 ', 6'-dimethoxybiphenyl) (1.2 g, 2.88 mmol), carbonic acid Cesium (14 g, 43.2 mmol), 80 mL of xylene, 40 mL of ethanol and 40 mL of distilled water were added thereto, and the mixture was stirred under reflux for 18 hours. Cooled to room temperature and distilled water was added. The organic layer was extracted with MC and dried over magnesium sulfate. Distillation under reduced pressure and separation by column chromatography gave Compound 30-2 (2.2 g, yield: 27%).
3) 화합물 30-3) Compound 30- 3 의3 of 합성 synthesis
플라스크에 화합물 30-2 (2.2 g, 3.8 mmol), 이튼 시약(Eaton's reagent) 2 mL 및 염화벤젠 13 mL을 넣고 18시간 동안 환류 교반하였다. 상온으로 냉각시키고 탄산수소나트륨 수용액을 넣었다. 아세트산에틸(EA)로 유기층을 추출하고 마그네슘 설페이트로 건조시켰다. 감압 증류하고 컬럼 크로마토그래피로 분리하여 화합물 30-3 (1.5 g, 수율: 71%)을 얻었다.To the flask was added Compound 30-2 (2.2 g, 3.8 mmol), 2 mL Eaton's reagent, and 13 mL benzene chloride, and the mixture was stirred under reflux for 18 hours. After cooling to room temperature, an aqueous sodium hydrogen carbonate solution was added. The organic layer was extracted with ethyl acetate (EA) and dried over magnesium sulfate. Distillation under reduced pressure and separation by column chromatography gave Compound 30-3 (1.5 g, yield: 71%).
4) 화합물 C-447의 합성4) Synthesis of Compound C-447
플라스크에 요오드 (244 mg, 0.96 mmol), 하이포아인산 (0.48 mL, 4.4 mmol, 50% 수용액) 및 아세트산 14 mL을 넣고 80℃에서 30분 간 교반하였다. 여기에 화합물 30-3 (1.5 g, 2.75 mmol)을 천천히 적가한 후 4시간 동안 환류교반하였다. 반응 용액을 상온으로 냉각하고 석출된 고체를 여과하고, 다량의 물과 에탄올로 씻어주었다. 생성된 고체는 필터를 통하여 용매를 제거하였다. 이 후 컬럼 크로마토그래피로 분리하여 화합물 C-447 (270 mg, 수율: 18%)을 얻었다.Iodine (244 mg, 0.96 mmol), hypophosphoric acid (0.48 mL, 4.4 mmol, 50% aqueous solution) and 14 mL of acetic acid were added to the flask, and the mixture was stirred at 80 ° C. for 30 minutes. Compound 30-3 (1.5 g, 2.75 mmol) was slowly added dropwise thereto, followed by stirring under reflux for 4 hours. The reaction solution was cooled to room temperature, and the precipitated solid was filtered and washed with a large amount of water and ethanol. The resulting solid removed solvent through a filter. Then separated by column chromatography to give the compound C-447 (270 mg, yield: 18%).
[[ 비교예Comparative example 1] 호스트로서 종래의 화합물을 포함하는 유기 1] organic containing a conventional compound as a host 전계Electric field 발광 소자의 제조 Manufacture of light emitting device
본원에 따르지 않는, 종래의 화합물을 호스트 재료로 사용한 OLED 소자를 제조하였다. 우선, OLED 용 글래스(지오마텍사 제조) 기판 상의 투명 전극 ITO 박막(10Ω/□)을 아세톤 및 이소프로필알코올을 순차적으로 사용하여 초음파 세척을 실시한 후, 이소프로판올에 넣어 보관한 후 사용하였다. 다음으로 진공 증착 장비의 기판 홀더에 ITO 기판을 장착한 후, 진공 증착 장비 내의 셀에 화합물 HI-1을 넣고 챔버 내의 진공도가 10-7 torr에 도달할 때까지 배기시킨 후, 셀에 전류를 인가하여 증발시켜 ITO 기판 위에 80 nm 두께의 제1 정공 주입층을 증착하였다. 이어서, 진공 증착 장비 내의 다른 셀에 화합물 HI-2를 넣고, 셀에 전류를 인가하여 증발시켜 제1 정공 주입층 위에 5 nm 두께의 제2 정공 주입층을 증착하였다. 이어서, 진공 증착 장비 내의 다른 셀에 화합물 HT-1을 넣고, 셀에 전류를 인가하여 증발시켜 제2 정공 주입층 위에 10 nm 두께의 제1 정공 전달층을 증착하였다. 이어서, 진공 증착 장비 내의 다른 셀에 화합물 HT-3를 넣고, 셀에 전류를 인가하여 증발시켜 제1 정공 전달층 위에 60 nm 두께의 제2 정공 전달층을 증착하였다. 정공 주입층과 정공 전달층을 형성시킨 후, 그 위에 발광층을 다음과 같이 증착시켰다. 진공 증착 장비 내의 한쪽 셀에 호스트로서 CBP를 넣고, 또 다른 셀에는 도판트로서 화합물 D-39를 각각 넣은 후, 두 물질을 다른 속도로 증발시켜 호스트와 도판트의 합계량에 대해 도판트를 3 중량%의 양으로 도핑함으로써 상기 제2 정공 전달층 위에 40 nm 두께의 발광층을 증착하였다. 이어서 상기 발광층 위에 전자 전달 재료로서 화합물 ETL -1:EIL -1을 50:50의 중량비로 35 nm 증착하였다. 이어서 전자 주입층으로 화합물 EIL -1을 상기 전자 전달층 위에 2 nm 두께로 증착한 후, 다른 진공 증착 장비를 이용하여 Al 캐소드를 상기 전자 주입층 위에 80 nm의 두께로 증착하여 OLED 소자를 제조하였다. 재료 별로 각 화합물은 10-6 torr 하에서 진공 승화 정제하여 사용하였다.OLED devices using conventional compounds as host materials, not according to the present application, were prepared. First, the transparent electrode ITO thin film (10 μs / □) on a glass for OLED (Geomatec Co., Ltd.) substrate was subjected to ultrasonic cleaning using acetone and isopropyl alcohol sequentially, and then stored in isopropanol and used. Next, the ITO substrate is mounted on the substrate holder of the vacuum deposition apparatus, the compound HI-1 is put into the cell in the vacuum deposition apparatus, and evacuated until the vacuum in the chamber reaches 10 -7 torr, and then a current is applied to the cell. By evaporation to deposit an 80 nm thick first hole injection layer on the ITO substrate. Subsequently, compound HI-2 was placed in another cell in the vacuum deposition equipment, and a second hole injection layer having a thickness of 5 nm was deposited on the first hole injection layer by applying an electric current to the cell to evaporate. Subsequently, Compound HT-1 was placed in another cell in the vacuum deposition equipment, and a current was applied to the cell to evaporate to deposit a first hole transport layer having a thickness of 10 nm on the second hole injection layer. Subsequently, Compound HT-3 was placed in another cell in the vacuum deposition equipment, and a second hole transport layer having a thickness of 60 nm was deposited on the first hole transport layer by evaporation by applying a current to the cell. After the hole injection layer and the hole transport layer were formed, the light emitting layer was deposited thereon as follows. Place CBP as a host in one cell in the vacuum deposition equipment, compound D-39 as a dopant in another cell, and then evaporate the two materials at different rates to add 3 weights of dopant to the total amount of host and dopant. A 40 nm thick light emitting layer was deposited on the second hole transport layer by doping in an amount of%. Subsequently, 35 nm of a compound ETL- 1 : EIL- 1 was deposited at a weight ratio of 50:50 as an electron transporting material on the light emitting layer. Subsequently, the compound EIL- 1 was deposited to a thickness of 2 nm on the electron transport layer using an electron injection layer, and then an Al cathode was deposited to a thickness of 80 nm on the electron injection layer using another vacuum deposition equipment to manufacture an OLED device. . For each material, each compound was used by vacuum sublimation purification under 10 −6 torr.
[소자 [device 제조예Production Example 1 내지 5] 본원에 따른 복수 종의 호스트 재료를 포함하는 유기 1 to 5] organic comprising a plurality of host materials according to the present application 전계Electric field 발광 소자의 제조 Manufacture of light emitting device
소자 제조예 1 내지 5에서는, 발광층을 진공 증착 장비 내의 셀 두 군데에 호스트로서 각각 하기 표 1에 기재된 제1 호스트 화합물 및 제2 호스트 화합물을 넣고, 또 다른 셀에는 D-39를 넣은 후, 두 호스트 물질을 1:1의 속도로 증발시키고 동시에 도판트 물질을 다른 속도로 증발시켜 호스트와 도판트의 합계량에 대해 도판트를 3 중량%의 양으로 도핑함으로써 상기 제2 정공 전달층 위에 40 nm 두께의 발광층을 증착한 것 외에는 비교예 1과 동일한 방법으로 OLED 소자를 제조하였다.In device fabrication examples 1 to 5, the first host compound and the second host compound described in Table 1 were respectively put as two hosts in two cells of the light emitting layer in the vacuum deposition equipment, and then D-39 was placed in another cell. 40 nm thick over the second hole transport layer by evaporating the host material at a rate of 1: 1 and at the same time evaporating the dopant material at a different rate to dope the dopant in an amount of 3% by weight relative to the total amount of host and dopant. An OLED device was manufactured in the same manner as in Comparative Example 1, except that the light emitting layer was deposited.
이상과 같이 제조된 비교예 1 및 소자 제조예 1 내지 5의 유기 전계 발광 소자의 5,000 nit 휘도 기준의 구동 전압, 발광 효율, 및 빛의 세기가 100%에서 98%로 떨어지는 데까지 걸리는 시간(수명; T98)을 하기 표 1에 나타내었다.The driving voltage, luminous efficiency, and time taken for the light intensity to fall from 100% to 98% of the organic electroluminescent devices of Comparative Example 1 and Device Preparation Examples 1 to 5 manufactured as described above (lifetime; T98) is shown in Table 1 below.
[표 1]TABLE 1
[소자 [device 제조예Production Example 6] 본원에 따른 복수 종의 호스트 재료를 포함하는 유기 6] organic comprising a plurality of host materials according to the present application 전계Electric field 발광 소자의 제조 Manufacture of light emitting device
소자 제조예 6에서는, 제2 정공 전달층 재료로서 화합물 HT-3 대신에 화합물 HT-2를 사용한 것과 발광층을 진공 증착 장비 내의 셀 두 군데에 호스트로서 각각의 제1 호스트 화합물(C-339) 및 제2 호스트 화합물(C-338)을 넣고, 또 다른 셀에는 D-39를 넣은 후, 두 호스트 물질을 1:1의 속도로 증발시키고 동시에 도판트 물질을 다른 속도로 증발시켜 호스트와 도판트의 합계량에 대해 도판트를 3 중량%의 양으로 도핑함으로써 상기 제2 정공 전달층 위에 40 nm 두께의 발광층을 증착한 것 외에는 비교예 1과 동일한 방법으로 OLED 소자를 제조하였다.In device fabrication example 6, the compound of the second hole transport layer instead of compound HT-3 The first host compound ( C-339 ) and the second host compound ( C-338 ) were used as the host in two cells of the compound HT-2 and the light emitting layer in the vacuum deposition equipment, and in another cell, D-39 And then evaporate the two host materials at a rate of 1: 1 and simultaneously evaporate the dopant material at a different rate to deliver the second hole by doping the dopant in an amount of 3% by weight relative to the total amount of host and dopant. An OLED device was manufactured in the same manner as in Comparative Example 1, except that a light emitting layer having a thickness of 40 nm was deposited on the layer.
이상과 같이 제조된 소자 제조예 6의 유기 전계 발광 소자의 1,000 nit 휘도 기준에서 구동 전압은 2.8 V, 발광 효율은 29.0 cd/A를 나타내었고, 5,000 nit 휘도 기준 빛의 세기가 100%에서 98%로 떨어지는 데까지 걸린 시간은 169.8시간이었다.The driving voltage was 2.8 V and the emission efficiency was 29.0 cd / A at 1,000 nit luminance of the organic electroluminescent device of Example 6 manufactured as described above, and the intensity of the light at 5,000 nit luminance was 100% to 98%. The time it took to fall to was 169.8 hours.
상기 표 1 및 소자 제조예 6으로부터, 본원의 복수 종의 호스트 재료를 포함하는 유기 전계 발광 소자는, 종래의 유기 전계 발광 화합물 1종을 포함하는 유기 전계 발광 소자에 비하여 낮은 구동 전압, 높은 발광 효율 및/또는 개선된 수명 특성을 가짐을 확인할 수 있다.From the above Table 1 and Device Manufacturing Example 6, the organic electroluminescent device comprising a plurality of host materials of the present application has a lower driving voltage and a higher luminous efficiency than an organic electroluminescent device containing one conventional organic electroluminescent compound. And / or improved lifetime characteristics.
상기 소자 실시예 및 비교예에 사용된 화합물을 하기 표 2에 나타내었다.The compounds used in the device examples and comparative examples are shown in Table 2 below.
[표 2]TABLE 2
Claims (9)
[화학식 1]
상기 화학식 1에서,
M은 , O 또는 S이고;
X1 내지 X12는 각각 독립적으로 N 또는 CR1이며;
La는 단일결합, 치환 또는 비치환된 (C1-C30)알킬렌, 치환 또는 비치환된 (C6-C30)아릴렌, 치환 또는 비치환된 (3-30원)헤테로아릴렌, 또는 치환 또는 비치환된 (C3-C30)시클로알킬렌이고;
Ar 및 R1은 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (3-30원)헤테로아릴, 치환 또는 비치환된 (C3-C30)시클로알킬, 치환 또는 비치환된 (C1-C30)알콕시, 치환 또는 비치환된 트리(C1-C30)알킬실릴, 치환 또는 비치환된 디(C1-C30)알킬(C6-C30)아릴실릴, 치환 또는 비치환된 (C1-C30)알킬디(C6-C30)아릴실릴, 치환 또는 비치환된 트리(C6-C30)아릴실릴, 치환 또는 비치환된 모노- 또는 디- (C1-C30)알킬아미노, 치환 또는 비치환된 모노- 또는 디- (C6-C30)아릴아미노, 또는 치환 또는 비치환된 (C1-C30)알킬(C6-C30)아릴아미노이거나; 인접한 Ar끼리 서로 연결되어 고리를 형성하거나, 인접한 R1끼리 서로 연결되어 고리를 형성할 수 있고, R1이 복수인 경우 각각의 R1은 서로 동일하거나 상이할 수 있으며;
a는 1 또는 2의 정수이고, a가 2인 경우, 각각의 Ar은 동일하거나 상이할 수 있다.A plurality of types of host materials including a first host compound and a second host compound, wherein the first host compound and the second host compound are represented by the following Chemical Formula 1, and the first host compound and the second host compound are different from each other. And a plurality of host materials:
[Formula 1]
In Chemical Formula 1,
M is , O or S;
X 1 to X 12 are each independently N or CR 1 ;
La is a single bond, substituted or unsubstituted (C1-C30) alkylene, substituted or unsubstituted (C6-C30) arylene, substituted or unsubstituted (3- to 30-membered) heteroarylene, or substituted or unsubstituted Ring (C3-C30) cycloalkylene;
Ar and R 1 are each independently hydrogen, deuterium, halogen, cyano, substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl, substituted or unsubstituted (3-30 Heteroaryl, substituted or unsubstituted (C3-C30) cycloalkyl, substituted or unsubstituted (C1-C30) alkoxy, substituted or unsubstituted tri (C1-C30) alkylsilyl, substituted or unsubstituted di (C1-C30) alkyl (C6-C30) arylsilyl, substituted or unsubstituted (C1-C30) alkyldi (C6-C30) arylsilyl, substituted or unsubstituted tri (C6-C30) arylsilyl, substituted or Unsubstituted mono- or di- (C1-C30) alkylamino, substituted or unsubstituted mono- or di- (C6-C30) arylamino, or substituted or unsubstituted (C1-C30) alkyl (C6-C30) Arylamino; Adjacent Ar are connected to each other to form a ring, or may form a ring are connected to each other, the adjacent R 1, if R 1 is plural, each of R 1 are the same or may be different from one another, and;
a is an integer of 1 or 2, and when a is 2, each Ar may be the same or different.
[화학식 2] [화학식 3] [화학식 4] [화학식 5] [화학식 6]
상기 화학식 2 내지 6에서,
R2는 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (3-30원)헤테로아릴, 치환 또는 비치환된 (C3-C30)시클로알킬, 치환 또는 비치환된 (C1-C30)알콕시, 치환 또는 비치환된 트리(C1-C30)알킬실릴, 치환 또는 비치환된 디(C1-C30)알킬(C6-C30)아릴실릴, 치환 또는 비치환된 (C1-C30)알킬디(C6-C30)아릴실릴, 치환 또는 비치환된 트리(C6-C30)아릴실릴, 치환 또는 비치환된 모노- 또는 디- (C1-C30)알킬아미노, 치환 또는 비치환된 모노- 또는 디- (C6-C30)아릴아미노, 또는 치환 또는 비치환된 (C1-C30)알킬(C6-C30)아릴아미노이고;
X는 N 또는 CH이며;
R11 및 R12는 각각 독립적으로 수소, 중수소, 할로겐, 시아노, 치환 또는 비치환된 (C1-C30)알킬, 치환 또는 비치환된 (C6-C30)아릴, 치환 또는 비치환된 (3-30원)헤테로아릴, 또는 치환 또는 비치환된 (C3-C30)시클로알킬이거나; 서로 연결되어 고리를 형성할 수 있으며;
는 CR1에서의 C와 R1의 연결 부위를 나타낸다.2. The compound of claim 1, wherein two adjacent X 1 to X 12 are CR 1 , and two adjacent R 1 are connected to each other to form a ring of Formula 2 to 6, wherein the ring is represented by Formula 1 Wherein at least one host material is formed from a compound of:
[Formula 2] [Formula 3] [Formula 4] [Formula 5] [Formula 6]
In Chemical Formulas 2 to 6,
R 2 is hydrogen, deuterium, halogen, cyano, substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl, substituted or unsubstituted (3- to 30-membered) heteroaryl, Substituted or unsubstituted (C3-C30) cycloalkyl, substituted or unsubstituted (C1-C30) alkoxy, substituted or unsubstituted tri (C1-C30) alkylsilyl, substituted or unsubstituted di (C1-C30) Alkyl (C6-C30) arylsilyl, substituted or unsubstituted (C1-C30) alkyldi (C6-C30) arylsilyl, substituted or unsubstituted tri (C6-C30) arylsilyl, substituted or unsubstituted mono- Or di- (C1-C30) alkylamino, substituted or unsubstituted mono- or di- (C6-C30) arylamino, or substituted or unsubstituted (C1-C30) alkyl (C6-C30) arylamino;
X is N or CH;
R 11 and R 12 are each independently hydrogen, deuterium, halogen, cyano, substituted or unsubstituted (C1-C30) alkyl, substituted or unsubstituted (C6-C30) aryl, substituted or unsubstituted (3- 30 membered) heteroaryl or substituted or unsubstituted (C3-C30) cycloalkyl; Can be linked to each other to form a ring;
Represents the joint of the C and R 1 of the CR 1.
[화학식 7] [화학식 8]
[화학식 9] [화학식 10]
상기 화학식 7 내지 10에서,
X1 내지 X12, 및 M은 제1항에서 정의된 바와 같다.The host material of claim 1, wherein Formula 1 is represented by at least one of Formulas 7 to 10:
[Formula 7] [Formula 8]
[Formula 9] [Formula 10]
In Chemical Formulas 7 to 10,
X 1 to X 12 , and M are as defined in claim 1.
The host material of claim 1, wherein the compound represented by Formula 1 is at least one selected from the following compounds.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2019/008086 WO2020009448A1 (en) | 2018-07-03 | 2019-07-02 | A plurality of host materials and organic electroluminescent device comprising the same |
CN201980044306.8A CN112352325A (en) | 2018-07-03 | 2019-07-02 | Multiple host materials and organic electroluminescent device comprising the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20180077056 | 2018-07-03 | ||
KR1020180077056 | 2018-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200004253A true KR20200004253A (en) | 2020-01-13 |
Family
ID=69153392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190078151A KR20200004253A (en) | 2018-07-03 | 2019-06-28 | A plurality of host materials and organic electroluminescent device comprising the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20200004253A (en) |
CN (1) | CN112352325A (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110862379A (en) * | 2019-10-23 | 2020-03-06 | 宇瑞(上海)化学有限公司 | Phosphorescent compound and organic light-emitting device using same |
CN111039931A (en) * | 2019-10-23 | 2020-04-21 | 宇瑞(上海)化学有限公司 | Phosphorescent compound and OLED device using same |
CN112939946A (en) * | 2019-12-10 | 2021-06-11 | 北京鼎材科技有限公司 | Compound and application thereof |
CN113735827B (en) * | 2021-08-12 | 2022-12-06 | 阜阳欣奕华材料科技有限公司 | Compound, organic electroluminescent device and display device |
CN113735835B (en) * | 2021-08-12 | 2022-12-06 | 阜阳欣奕华材料科技有限公司 | Compound, organic electroluminescent device and display device |
CN113735831B (en) * | 2021-08-16 | 2022-12-06 | 阜阳欣奕华材料科技有限公司 | Compound, intermediate, preparation method of compound and intermediate, and organic electroluminescent device |
CN114349741B (en) * | 2021-12-31 | 2023-03-24 | 武汉天马微电子有限公司 | Organic compound and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150121337A (en) | 2014-04-18 | 2015-10-29 | 덕산네오룩스 주식회사 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
-
2019
- 2019-06-28 KR KR1020190078151A patent/KR20200004253A/en not_active Application Discontinuation
- 2019-07-02 CN CN201980044306.8A patent/CN112352325A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150121337A (en) | 2014-04-18 | 2015-10-29 | 덕산네오룩스 주식회사 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112352325A (en) | 2021-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102550601B1 (en) | Organic electroluminescent compound, a plurality of host materials and organic electroluminescent device comprising the same | |
KR20200004253A (en) | A plurality of host materials and organic electroluminescent device comprising the same | |
KR20200049635A (en) | Organic electroluminescent compound and organic electroluminescent device comprising the same | |
KR102302838B1 (en) | Organic electroluminescent compound and organic electroluminescent device comprising the same | |
KR102306966B1 (en) | Organic electroluminescent compound, a plurality of host materials, and organic electroluminescent device comprising the same | |
KR20200026083A (en) | A plurality of host materials and organic electroluminescent device comprising the same | |
KR20200011884A (en) | A plurality of host materials and organic electroluminescent device comprising the same | |
KR20200026747A (en) | Organic electroluminescent device | |
KR20200043269A (en) | A plurality of host materials and organic electroluminescent device comprising the same | |
US11950506B2 (en) | Plurality of host materials and organic electroluminescent device comprising the same | |
US20220162210A1 (en) | Organic electroluminescent compound and organic electroluminescent device comprising the same | |
KR20220051794A (en) | Organic electroluminescent compound, a plurality of host materials and organic electroluminescent device comprising the same | |
CN113444096A (en) | Multiple host materials and organic electroluminescent device comprising the same | |
KR20190101281A (en) | Organic electroluminescent compound and organic electroluminescent device comprising the same | |
KR20220013315A (en) | Organic electroluminescent compound, a plurality of host materials and organic electroluminescent device comprising the same | |
KR102582803B1 (en) | Organic electroluminescent compound and organic electroluminescent device comprising the same | |
KR20210124018A (en) | Organic electroluminescent compound, a plurality of host materials, and organic electroluminescent device comprising the same | |
KR20210116214A (en) | Organic electroluminescent compound and organic electroluminescent device comprising the same | |
KR20210082068A (en) | Organic electroluminescent compound, organic electroluminescent material comprising the same, and organic electroluminescent device | |
CN112920179A (en) | Organic electroluminescent compounds and organic electroluminescent device comprising the same | |
CN114380734A (en) | Organic electroluminescent compounds, various host materials and organic electroluminescent device comprising the same | |
CN112239666A (en) | Multiple host materials and organic electroluminescent device comprising the same | |
KR20200018275A (en) | Organic electroluminescent compound and organic electroluminescent device comprising the same | |
KR20210010310A (en) | A plurality of host materials and organic electroluminescent device comprising the same | |
KR20200011873A (en) | Organic electroluminescent compound and organic electroluminescent device comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal |